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Abstract
Programmed cell death, or apoptosis, is important in the development and
homeostasis of metazoans. In the nematode C. elegans, four genes, egl-1, ced-9, ced-4, and
ced-3, constitute the core pathway acting in all somatic programmed cell deaths. This
pathway is evolutionarily conserved in humans. The BH3-only protein EGL-1 is
transcriptionally upregulated in cells fated to undergo programmed cell death, and EGL-1
blocks cell-death inhibition by the cell-death regulator CED-9, a Bcl-2 family member. The
binding of EGL- 1 to CED-9 releases the Apaf- 1-like adaptor protein CED-4 from CED-9, so
that CED-4 can activate the caspase CED-3, a protease that is the effector of programmed
cell death. In this thesis, I describe three projects, each of which examines one aspect of C.
elegans cell death.
From. screens for mutations that increase cell death in a sensitized genetic
background, I identified a gene that protects cells from programmed cell death. This gene,
spk-1, encodes a homolog of SR protein kinases, which regulate alternative splicing.
Previous work has shown that ced-4 pre-mRNA is alternatively spliced to generate two
transcripts that function oppositely in cell death. I found that spk-1 regulates ced-4 transcript
splicing, thereby influencing the amount of programmed cell death that occurs.
From a screen for genes that promote programmed cell death, I isolated a mutation
in a conserved non-coding element in the transcriptionally regulated cell-death activator gene
egl-1. This element regulates the deaths of specific cells in the C. elegans ventral nervous
system. I found a novel C. elegans transcription factor, Y38C9A. 1, that binds this element
and might function to regulate egl-1 transcription and programmed cell death in the ventral
nervous system.
In addition to the programmed cell deaths that occur in C. elegans, pathological death
of specific cells can be caused by mutations in some genes. I characterized two genes, lin-24
and lin-33, that can mutate to cause the inappropriate death of specific hypodermal blast
cells. One of these genes, lin-24, contains a domain similar to that found in some bacterial
toxins. By morphological and genetic criteria, I show that the lin-24- and lin-33-mediated
deaths are unlike previously characterized necrotic and apoptotic cell deaths in C. elegans.
These deaths require some of the genes responsible for engulfing the corpses generated by
programmed cell death, even though the deaths do not require the core genes of the genetic
pathway of programmed cell death.
Thesis Advisor: H. Robert Horvitz
Title: Professor of Biology
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I. INTRODUCTION
Initially it seems counterintuitive that cells would posses the ability to kill
themselves. However, considering that damaged, infected, or unnecessary cells might harm
an organism, the ability to eliminate such cells in a safe way is clearly important. One of the
most intuitive examples of a type of cell that should be eliminated are cells in the immune
system that recognize self-antigens; such cells can destroy healthy tissues if allowed to
persist in the body (FADEEL and ORRENIUS 2005).
The process of cellular elimination, which functions in many different processes, has
long fascinated researchers. In 1842, Carl Vogt published a paper that many cite as the first
to describe the cell-death process that would later become known as programmed cell death
or apoptosis. In this manuscript, Vogt described cell deaths that occurred in toads as they
underwent metamorphosis (CLARKE and CLARKE 1996). Over the next century additional
papers reported descriptions of similar phenomena in other systems, ranging from ovarian
follicles to neurons in the chick embryo (CLARKE and CLARKE 1996). In 1965, Lockshin and
Williams proposed the term programmed cell death to describe the deaths they observed
during insect development (LOCKSHIN and WILLIAMS 1965). Kerr, Wyllie, and Currie
introduced the term apoptosis in 1972 to describe cellular death that occurs with a specific set
of ultrastructural features (KERR et al. 1972).
Apoptosis is the efficient process of eliminating cells in a manner that prevents the
release of cellular contents in order to prevent the consequent deleterious effects such as
activation of an inflammatory response. Apoptosis functions in many aspects of human
development, from sculpting tissues (e.g. removing the webbing between fingers) to
eliminating excess neurons in the central nervous system (JACOBSON et al. 1997). When the
- 11 -
normal functions of apoptosis do not work properly, a wide range of consequences can result.
For example, cancerous cells have frequently lost the ability to undergo apoptosis in response
to uncontrolled growth. Conversely, several neurodegenerative disorders are marked by, and
may result from, the inappropriate activation of too much apoptosis (FADEEL and ORRENIUS
2005).
Although the phenomenon of programmed cell death has been observed and written
about for more than 150 years, confirmation that this process is genetically controlled is only
twenty years old, and the identification of the genes that regulate this process is still very
much an ongoing process. Genetic, cellular, and biochemical studies have all contributed
significantly to our current understanding of programmed cell death (DANIAL and
KORSMEYER 2004).
The identification of three genes in the nematode Caenorhabditis elegans, ced-3,
ced-4, and ced-9, defined the basic components of programmed cell death or apoptosis that
function in all systems (HORVITz 2003). In this introduction I will give an overview of the
current state of research of programmed cell death in C. elegans and how it relates to our
understanding of apoptosis in mammals. I will discuss how cells decide to live or die, how
execution of programmed cell death occurs once a cell has made this decision, and how cell
corpses are eliminated. I will also mention a few types of cell deaths that occur in C. elegans
that are morphologically and genetically distinct from programmed cell death. Finally, I will
summarize mechanisms that function in mammalian or insect apoptosis but have not been
described in C elegans.
II. DEVELOPMENTAL PROGRAMMED CELL DEATH IN C. ELEGANS
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A. The History of Genetic Studies of Programmed Cell Death in C. elegans
C. elegans is the small nematode that Sydney Brenner wisely selected for genetic
characterization (BRENNER 1974). Early in the development of C. elegans as a system for
genetic research, John Sulston determined the cell lineage of the ventral nerve cord (SULSTON
1976). Bob Horvitz and others joined Sulston in this pioneering effort and determined the
complete lineage of all cells in this nematode (KIMBLE and HIRSH 1979; SULSTON and
HORVITZ 1977; SULSTON et al. 1983). The pattern of somatic cell division is almost identical
in every individual worm, such that the origin and identity of every cell from fertilization to
adulthood is known. The pattern of cell divisions has been drawn up into a complete lineage
diagram for C. elegans. This lineage map has proven to be a great resource in studies of
developmental biology.
Sulston and Horvitz observed that some of the cells generated in the post-embryonic
cell lineage were rapidly eliminated in a highly-stereotyped fashion (SULSTON and HORVITZ
1977). One hundred and thirty-one of the 1,030 somatic cells that are generated in the
C. elegans hermaphrodite undergo this stereotyped elimination; of these, 105 are neurons
(SULSTON and HORVITZ 1977; SULSTON et al. 1983). The genetic foundations that Sydney
Brenner established for this organism suggested the possibility that it might be possible to
isolate mutations perturbing this pattern of programmed cell death.
In an effort to identify genes that control the cell lineage of the ventral nerve cord,
John Sulston identified an allele of a gene, nuc-1 (nuc, abnormal nuclease), that prevented
the degradation of DNA of cells that died by programmed cell death (SULSTON 1976). Next,
Ed Hedgecock isolated ced-1 and ced-2 (ced, cell death abnormal) mutant alleles that
blocked the phagocytosis of dead cells by neighboring cells (HEDGECOCK et al. 1983).
-13-
Although it would be many years before any of these genes were molecularly identified, their
isolation was a significant contribution to this field of research. The long-term study of
programmed cell death in Bob Horvitz's laboratory led to the identification of the principal
genes that function in apoptosis in all animals (HoRVITZ 2003). Important to the success of
C. elegans's role in defining the basics of programmed cell death is that, unlike most other
animals, C. elegans are viable in the absence of programmed cell death (ELLIS and HORVITZ
1986). This trait has greatly facilitated much of the progress towards understanding of
programmed cell death that has been made using this organism.
Since the identification of nuc-1, hundreds of alleles of genes that alter programmed
cell death have been isolated; for example in the Horvitz laboratory alone, more than 200
alleles of the gene ced-3 have been identified as of this writing. Figure 1 shows a schematic
of how the best understood of these genes fit into our current model of programmed cell
death.
B. The Four Genes ced-3, ced-4, ced-9, and egl-1 Define a Core Programmed Cell Death
Pathway that is Conserved in Most Animals
1. ced-3 encodes a cysteineprotease
One of the first programmed cell death genes in C. elegans to be molecularly
identified is ced-3, and its identification may be the most important. In a screen to identify
suppressors of the persistent programmed cell death corpses observed in mutant ced-1
animals, ced-3 alleles that eliminated these corpses were identified (ELLIS and HORVITZ
1986). Close inspection of these mutant animals showed that almost none of the cells that
normally died during C. elegans development died in these mutants; rather, these cells
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survived and showed signs of differentiation (ELLIS and HORVITZ 1986). The cells that
survive in ced-3 mutant worms have not been found to subsequently divide and often adopt a
cell fate similar to that of their sister cell. These inappropriately surviving cells can, in some
cases, even functionally replace their sister cells (AVERY and HORVITZ 1987).
Years later, ced-3 was cloned and found to be similar to the mammalian protease
interleukin- 13 P-converting enzyme (ICE) (YUAN et al. 1993). The discovery that CED-3 was
a protease provided the first mechanistic insight into apoptosis. CED-3 and ICE were the
founding members of the cysteine proteases, or caspases (cysteine aspartate-specific
protease), that have been shown to function as key effectors of apoptosis in all systems
(DEGTEREV et al. 2003). Although ced-3 is the only caspase known to function in C.
elegans, three other caspase-like genes have been identified and remain to be genetically
characterized (SHAHAM 1998). ced-3 is required in cells fated to undergo programmed cell
death, demonstrating that this gene acts cell-autonomously in a process of cellular suicide
(YUAN and HORVITZ 1990). When overexpressed in cells that do not normally die in C.
elegans, ced-3 can cause their deaths by a process that shares morphological and genetic
features with normal programmed cell deaths (SHAHAM and HORVITZ 1996b).
Caspases such as CED-3 are synthesized as inactive zymogens and become active
only when they are cleaved, usually through autocleavage or by other proteases, particularly
other caspases. The cleavage liberates two subunits, e. g. p20 and p10 (RAMAGE et al. 1995;
YAMIN et al. 1996), which heterodimerize to form an active caspase complex composed of
two p20 subunits and two p10 subunits (WALKER et al. 1994).
In mammals and D. melanogaster, the apoptotic caspases can be divided into two
classes, the initiator caspases and the effector caspases. The distinction between initiator and
-15-
effector caspases does not appear relevant to cell death in C. elegans, in which only the
caspase CED-3 has been shown to act. The initiator caspases, which resemble CED-3, are
characterized by a long prodomain that can function to mediate protein-protein interactions
with upstream regulatory molecules (DEGTEREV et al. 2003). These caspases generally
function by activating the effector caspases, which are characterized by their short
prodomains. Once activated, these effector caspases cleave substrates directly involved in
the process of apoptosis. Initiator caspases possess substrate preferences that make them
better suited to the cleavage and activation of effector caspases than to the cleavage of
downstream substrates (THORNBERRY et al. 1997). There are numerous mammalian
caspases; some of them, such as caspases 3, 6, 7, 8, 9, and 10, have well-established roles in
programmed cell death (SADOWSKI-DEBBING et al. 2002). In all systems, the final stage in
the regulation of apoptosis appears to be the determination of the level of caspase activity.
2. ced-4 encodes an adaptor protein that is similar to Apaf-1 and activates CED-3
As a direct result of the ced-1 suppression screen that identified alleles of ced-3,
screens were performed that recovered a mutant allele of ced-4 (ELLIS and HORVITZ 1986).
Unlike the molecular identification of ced-3, the cloning of ced-4 failed to immediately
provide insight into its function (YUAN and HORVITZ 1992). Like ced-3, ced-4 is required for
essentially all programmed cell deaths and acts cell-autonomously (YUAN and HORVITZ
1990). Genetic analysis suggests that ced-4 functions upstream of ced-3. Specifically,
overexpression of ced-4 in the presence of ced-3 causes robust cell killing, whereas without
ced-3, this overexpression of ced-4 does not kill efficiently. Additionally, overexpression of
ced-3 without ced-4 does kill (SHAHAM and HORVITZ 1996b). Biochemical experiments
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using various assays suggested that CED-4 binds to CED-3 and facilitates its activation
(CHINNAIYAN et al. 1997; SESHAGIRI and MILLER 1997; Wu et al. 1997; YANG et al. 1998).
CED-4 has a caspase activation and recruitment domain (CARD) and an AAA ATPase
domain. The CARD domain allows CED-4 to interact with and activate CED-3. The
function of the putative ATPase domain remains to be established.
Analysis of the ced-4 cDNAs of the genomic loci of ced-4 and its homolog in the
closely related nematodes C. briggsae and C. vulgaris led to the discovery that there are at
least two splice variants of ced-4: the principal splice variant, ced-4S, comprising -90% of
observed messages, and an alternate splice variant, ced-4L, containing an extra 72
nucleotides within the coding sequence (SHAHAM and HORVITZ 1996a). The two ced-4
splice variants appear to function oppositely in programmed cell death: the short variant
ced-4S promotes programmed cell death, whereas the long variant ced-4L may promote cell
survival (SHAHAM and HORVITZ 1996a). In Chapter 2, I present the characterization of the
spk-1 gene, which is a modifier of ced-4 killing activity and a regulator of the alternative
splicing of ced-4 in vivo.
The best-studied mammalian homolog of CED-4 was identified from a
labor-intensive biochemical purification in the laboratory of Xiaodong Wang. This approach
led to the identification of three fractions that were required for Caspase-3 cleavage, a
hallmark of mammalian apoptosis, in a cell-free system. One of these fractions contained the
CED-4 homolog Apaf- 1 (Zou et al. 1997). Like CED-4, Apaf- 1 binds to a caspase
(Caspase-9, called Apaf-3 in this biochemical purification scheme) through interaction with
its long prodomain, thereby promoting its activation (LI et al. 1997). Apaf-l-deficient mice
have reduced apoptosis in the brain, hyperproliferation of neuronal cells, and their cells are
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resistant to numerous apoptotic stimuli (CECCONI et al. 1998; YOSHIDA et al. 1998).
However, much of the cell death that occurs in the immune system proceeds normally in
Apaf- 1-deficient mice. Apaf- 1 shares two of three domains with CED-4: the CARD domain
and the ATPase domain. The third domain, which exists in Apaf- 1 but not in CED-4,
mediates interactions with cytochrome c (ACEHAN et al. 2002). The release of the
mitochondrial protein cytochrome c into the cytoplasm is an important triggering step in
many forms of programmed cell death in mammals, but its role in programmed cell death in
C. elegans has not been examined (LI et al. 1997).
3. ced-9 encodes a protective protein that is similar to the oncoprotein Bcl-2
In a screen to identify mutations that cause cell survival in C. elegans, a
gain-of-function allele of ced-9 was identified, ced-9(n1950gf) (HENGARTNER et al. 1992).
This allele, like loss-of-function alleles of ced-3 and ced-4, prevents apoptosis in essentially
all somatic cells that normally undergo programmed cell death (HENGARTNER et al. 1992).
Molecular identification of ced-9 showed that it encodes a protein similar to the
proto-oncoprotein Bcl-2 (HENGARTNER and HORVITZ 1994b). In some follicular lymphomas,
Bcl-2 is misexpressed in B cells as the result of a chromosomal translocation (BAKHSHI et al.
1985; CLEARY et al. 1986; TSUJIMOTO and CROCE 1986). Overexpression of Bcel-2 can
protect cells against apoptosis (HOCKENBERY et al. 1990; VAUX et al. 1988; VAUX et al.
1992). The observation that Bcl-2 could functionally replace CED-9 in C. elegans provided
the first molecular evidence for the existence of a programmed cell death pathway conserved
from nematodes to mammals (HENGARTNER and HORVITZ 1994b).
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Loss-of-function alleles of ced-9 cause cells that normally survive to die in a process
dependent on the cell-death genes ced-3 and ced-4 (HENGARTNER et al. 1992). Since
elimination of either ced-3 or ced-4 prevents the increased death observed in ced-9(If) (loss
of function) animals, ced-9 was proposed to act genetically upstream of ced-4 and ced-3
(HENGARTNER et al. 1992). Similar to Bcl-2 overexpression in mammalian systems,
overexpression of ced-9 can block normally-occurring programmed cell deaths in C. elegans
(HENGARTNER and HORVITZ 1994b). ced-9 also has a cell-killing function that can be
observed in genetically sensitized backgrounds (HENGARTNER and HORVITZ 1994a).
Of all the gene families that function in mammalian programmed cell death, the Bcl-2
family is the most complicated. The family members that behave most like CED-9 and Bcl-2
(i. e. they are anti-apoptotic), which include Bcl-xL, Bcl-w, Mcl-1 and Al, generally have
four domains found in Bcl-2, known as the Bcl-2 Homology (BH) domains (KUWANA and
NEWMEYER 2003). The other main family of Bcl-2 homologs, the pro-apoptotic family, is
discussed in the next section.
The observation that many of the Bcl-2 family members are localized to the
mitochondria contributed to the hypothesis that mitochondria function in apoptosis (DANIAL
and KORSMEYER 2004; HOCKENBERY et al. 1990). At the mitochondria, members of the
Bcl-2 family may form channels or otherwise regulate the release of apoptosis-promoting
factors from the mitochondria into the cytoplasm. The identification of cytochrome c,
normally found between the inner and outer membranes of the mitochondria, as an important
regulator of apoptosis further implicated mitochondria in apoptosis (LI et al. 1997). Bcl-2
family members may directly mediate release of cytochrome c (KUWANA and NEWMEYER
2003). Several additional functions for mitochondria in apoptosis have been described and
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numerous apoptotic mitochondrial associated-proteins have been described, but many remain
the subject of debate and none is as well established as cytochrome c (KUWANA and
NEWMEYER 2003). In mammals, the apoptotic pathway that involves the release of
cytochrome c from the mitochondria is usually described as the 'intrinsic' pathway, to
differentiate it from an 'extrinsic' pathway, which involves extracellular pro-apoptotic
ligands and does not necessarily act through the mitochondria. The intrinsic pathway is very
important in developmental cell deaths and is the pathway that regulates stress-induced
apoptosis such as that caused by DNA damage or the withdrawal of cytokines.
4. egl- 1 encodes a pro-apoptotic BH-3-only protein
The most upstream gene that functions in the execution of programmed cell death
was the last of the execution genes to be molecularly identified. A cell-specific
gain-of-function allele of this gene, egl-1 (egl, egg-laying abnormal), was originally
identified in a screen for animals that failed to properly lay eggs (TRENT et al. 1983). This
failure to lay eggs results from the mutant animals' lack of the HSNs (HSN,
hermaphrodite-specific neuron), which control egg laying. The inappropriate HSN deaths
and the egg-laying defect in this mutant were completely suppressed by loss of ced-3
function, suggesting that the inappropriate activation of the programmed cell death pathway
in the HSNs was causing the inappropriate death of these cells (ELLIS and HORVITZ 1986).
When intragenic suppressors of this dominant egl-1 allele were isolated, a remarkable
observation was made: not only were the revertants no longer egg-laying defective, but the
HSN neurons of the revertant hermaphrodites no longer died, and essentially none of the 131
somatic developmental programmed cell deaths that occur in wild-type hermaphrodites
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occurred in the revertant strains (CONRADT and HORVITZ 1998). Genetic analysis suggested
that egl-1 was functioning upstream of all the execution genes (ced-3, ced-4, and ced-9) to
regulate cell death. Further analysis showed that egl-1 is likely transcribed only in cells
developmentally fated to die and that the misexpression of EGL-1 can cause cells to die with
morphological and genetic characteristics of programmed cell death.
Molecular identification established that egl-1 encodes a BH3-only protein. This
family of proteins is defined by the possession of only one of the four Bcl-2 homology
domains. Mammalian BH3-only proteins are all pro-apoptotic and regulated in numerous
ways, including transcription (WILLIS and ADAMS 2005). A second gene encoding a C.
elegans BH3-only protein, ced-13, has been identified and might play a secondary role in
C. elegans cell death, specifically in the germline (SCHUMACHER et al. 2005). The
pro-apoptotic BH3-only family in mammals includes the proteins Bim, Bad, Bid, Bik, Bmf,
Puma, Noxa, and Hrk, which are generally activated in response to specific types of cellular
damage. In addition to transcriptional control analogous to that seen in C. elegans (Puma
and Noxa (HAN et al. 2001; NAKANO and VOUSDEN 2001; ODA et al. 2000; Yu et al. 2001)),
mechanisms that regulate the activity of mammalian BH3-only proteins include cleavage
(Bid (LI et al. 1998; Luo et al. 1998)), phosphorylation (Bad (ZHA et al. 1996)), and
sequestration to components of the cytoskeleton (Bmf (PUTHALAKATH et al. 2001) and Bim
(PUTHALAKATH et al. 1999)).
C. A Molecular Model For the Function of CED-3, CED-4, CED-9, and EGL-1
A combination of cell biological, biochemical, and structural experiments has
contributed to a compelling model for how the protein products of egl-1, ced-9, ced-4, and
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ced-3 function in programmed cell death. In C. elegans, CED-9 is permanently localized to
the mitochondria (CHEN et al. 2000), where it binds a dimer of CED-4 molecules (YAN et al.
2005). In cells that are fated to die, newly transcribed and translated EGL-1 binds to a
surface on CED-9, causing a conformational change that releases the CED-4 dimer from
CED-9 and the mitochondria. Upon release, CED-4 assembles into a complex containing
four CED-4 molecules (YAN et al. 2005) and localizes to the nuclear membrane (CHEN et al.
2000). This tetramer of CED-4 molecules binds CED-3 and promotes the autoproteolytic
activation of CED-3 (YAN et al. 2005). This activation of the protease activity of CED-3
causes cell death. The gain-of-function mutation ced-9(n1950) alters the interaction surface
with EGL- 1 and prevents its binding, thus preventing liberation of CED-4 and cell death
(YAN et al. 2004). The protective CED-4L is believed to protect by preventing the formation
of the CED-4 tetramers and the consequent activation of CED-3 (YAN et al. 2005).
Although counterparts of each of these components exists and functions in
mammalian cell death, aspects of the molecular mechanisms of programmed cell death might
differ between worms and mammals. BH3-only proteins in mammals do interact with Bcl-2
family members, but they probably regulate the release of mitochondrial proteins such as
cytochrome c (KUWANA and NEWMEYER 2003). Unlike in C. elegans, mammalian Bcl-2
family members are likely not to interact with Apaf- 1 and thus do not activate Apaf- 1 by
disassociation. Instead, Bcl-2 family members are thought to prevent the release of
cytochrome c from mitochondria and thereby prevent cytochrome c from stimulating the
aggregation of Apaf-1 and subsequent Caspase-9 activation.
D. Morphology of Cells Undergoing Programmed Cell Death in C. elegans
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Cell death in C. elegans can be easily observed using Nomarski
differential-interference contrast microscopy. Cells progress through several morphological
phases as they are dying, and the ultrastructures of these phases have been described
(ROBERTSON and THOMSON 1982). At the time of its generation, a cell that is destined to die
is usually smaller than its sister and, even before cell division is complete, is sometimes
recognized by neighboring engulfing cells. After a period of decreased refractility with little
change in cellular architecture, the nucleus appears increasingly refractile when observed by
Nomarski. At this stage, electron microscopy (EM) shows that the cytoplasm begins to
shrink, the nuclear membranes dilate, and chromatin aggregates begin to form in the nucleus.
Next, the entire cell appears refractile and adopts the classic button-like appearance seen with
Nomarski optics. Ultrastructurally the nucleus becomes dense, very little cytoplasm is
observed, and there is an increase in whorling of internal and plasma membranes. Finally the
cell shrinks and disappears, and traces of the corpse can be observed by EM in the engulfing
cells. This entire process takes less than an hour in the wild type, but can take several hours
in mutants partially compromised in their cell death machinery. Several of these features,
including condensation of cytoplasm and chromatin aggregation, are observed in mammalian
apoptosis, but others, such as membrane whorls, are not.
E. Engulfment of Programmed Cell Death Corpses
Following the death of cells and the generation of corpses, the corpses are engulfed
by neighboring cells. The first genes shown to function in the engulfment of programmed
cell death corpses, ced-1 and ced-2, were isolated by Ed Hedgecock in a genetic screen using
Nomarski microscopy to identify animals with any abnormality (HEDGECOCK et al. 1983). In
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animals lacking either ced-1 or ced-2 function, unlike in wild-type animals, the cell corpses
that were generated by developmental cell death often persist. Whereas in wild-type animals
the cell corpses would rapidly disappear, usually within 30 minutes of their generation, the
cell corpses of engulfment-defective mutants can persist for hours. This original screen was
followed up by additional screens and characterization in the Horvitz laboratory, in which
alleles of six additional engulfment genes were isolated (ELLIS and HORVITZ 1991; YU et al.
2006; ZHOU et al. 2001a).
The eight engulfment genes fall into two partially redundant pathways required for
programmed cell death corpse removal: the ced-1, -6, -7 and dyn-1 (dynamin) pathway and
the ced-2, -5, -10, -12 pathway. I will refer to the former as the ced-1 pathway and the latter
as the ced-2 pathway for the remainder of this chapter. Animals lacking the function of two
genes within either pathway do not cause the appearance of more persistent cell corpses than
those visible in animals with a single mutation. However, in animals lacking the function of
cell corpse engulfment genes from each of the two pathways, many more cell corpses persist
than in animals with either of the two mutations on their own (ELLIS et al. 1991; GUMIENNY
et al. 2001; WU et al. 2001; Yu et al. 2006; ZHOU et al. 2001 a). Careful analysis of which
cell corpses persisted in animals with specific alleles suggested that the two pathways are not
responsible for engulfing different subsets of cells, but rather are each providing functions
partially required for all cell corpse engulfment events (ELLIS et al. 1991).
Recent evidence indicates that the engulfment genes function not only in cell corpse
removal but also in cell killing (REDDIEN et al. 2001). Removal of a single engulfment gene
alone can very weakly promote the survival of cells that normally die. In a sensitized genetic
background, such as in the presence of a weak ced-3 loss-of-function allele that by itself
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promotes only a small amount of cell survival, elimination of any engulfment gene greatly
increases the amount of survival (REDDIEN and HORVITZ 2004). It is believed that, as the cell
begins to die, it generates surface markers that neighboring cells recognize; these
neighboring cells then begin to engulfment the dying cell and assist in promoting the cell's
death.
1. The ced-1, ced-6, ced-7, dyn-1 pathway functions in recognizing and labeling corpses
The mechanism of action of the genes that function in the ced-1 pathway is not
entirely clear, despite the fact that some of these genes are homologous to mammalian
proteins with known functions. The genes ced-1, -6, and -7 appear to function only in the
removal of programmed cell death corpses, as no additional abnormalities are associated with
mutations in these genes. ced-1 encodes a protein that is a receptor containing sixteen copies
of an atypical EGF-like repeat in its extracellular domain (ZHOU et al. 2001b). The short
intracellular domain of CED-1 contains tyrosines that might be phosphorylated to regulate
the binding of SH2 and PTB (phospho-tyrosine binding) domain containing proteins (ZHOU
et al. 2001b). The mammalian protein that most closely resembles CED-1 is mEGF10, a
mouse protein of unknown function that is related to receptors that have been shown to
function in mediating the phagocytosis of apoptotic cells in cell culture assays (MANGAHAS
and ZHOU 2005). Analysis using GFP-tagged versions of CED- 1 suggests that CED- 1
aggregates around cell corpses during their engulfment, suggesting that CED-1 functions in
recognizing the cell corpse (ZHOU et al. 2001b). Targeted expression suggests that ced-1
functions in cells responsible for engulfment (rather than in cells that die). Identification of
the ligand that CED-1 recognizes on the corpse remains an important unanswered question in
-25 -
programmed cell death.
ced-6 encodes an adaptor protein containing a PTB domain that has been shown to be
capable of interacting with CED-1 (LIu and HENGARTNER 1998; Su et al. 2002). CED-6 also
contains both a leucine zipper and a proline rich C-terminus, each of which may mediate
protein-protein interactions. A mammalian homolog of CED-6 (hCED-6, also called GULP)
(LIu and HENGARTNER 1999; SMITS et al. 1999), which was identified on the basis of its
homology to CED-6, can promote the engulfment of apoptotic cells in mammalian cell
culture when overexpressed. Like ced-1, ced-6 is thought to function in cells responsible for
engulfment. Because ced-6 is not required for the clustering of CED- 1::GFP in response to
apoptotic cells, ced-6 might act downstream of ced-1 (ZHOU et al. 2001b).
CED--7 is an ATP-binding cassette (ABC) transporter (Wu and HORVITZ 1998a).
ABC transporters comprise a large family of proteins that actively transport a wide variety of
substances (including lipids, sugars, and proteins) across membranes (KLEIN et al. 1999).
Unlike ced-1 and ced-6, ced-7 is thought to function in both the engulfing cells and the dying
cells, although the significance of this result remains unclear (Wu and HORVITZ 1998a).
Elimination of ced- 7, but not the elimination of ced-6 or other engulfment genes, prevents the
accumulation of CED- 1::GFP around cell corpses (ZHOU et al. 200 lb). Because ced- 7 is
required in the dying cells and is homologous to ABC transporters, ced- 7 may be responsible
for placing a signal that promotes recognition by CED- 1 on the surface of the cell corpse.
Although such a signal has not been identified, one strong candidate molecule is
phosphatidylserine (MANGAHAS and ZHOU 2005).
Recent work has identified a fourth member of this pathway, dyn-1. dyn-1 encodes a
large GTPase homologous to dynamin, which in other systems plays well-established roles in
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vesicle trafficking (Yu et al. 2006). Unlike the other genes in the ced-1 pathway, dyn-1 is
essential. EM analyses suggest that inactivation of dyn-1 prevents the fusion of intracellular
vesicles to the plasma membrane at the site of corpse engulfment. The dyn-1 work suggests
a model in which CED-1 responds to the presence of a cell corpse by accumulating on the
surface of the cell next to the cell corpse. The CED-1 proteins then send intracellular signals,
likely via CED-6, to recruit intracellular vesicles. This recruitment of vesicles to the plasma
membrane is regulated by DYN-1 and allows for extension of the cell membrane around the
corpse and engulfment.
2. The proteins CED-2, CED-5, CED-10O, and CED-12 are similar to mammalian proteins
that regulate cytoskeletal reorganization
Unlike the members of the ced-1 pathway, whose mechanisms of action are
somewhat unclear, each member of the ced-2 pathway has a clearly identifiable mammalian
homolog that functions in cytoskeletal reorganization. Cytoskeletal reorganization is
required for many different cellular processes, including cell migration, cell process
extension, and phagocytosis. In C. elegans, ced-2, -5, -10, and -12 also function in distal tip
cell migration, highlighting their involvement in other processes in C. elegans that require
cytoskeletal reorganization.
CED-10 is most similar to mammalian Rac 1 (REDDIEN and HORVITZ 2000), which is
a member of the Ras GTPase superfamily that includes Rho, Rac, and Cdc42. Each of these
proteins has a well-established role in cytoskeletal reorganization (JAFFE and HALL 2005).
CED-5 is most similar to DOCK180 and is a member of the CDM protein (CED-5,
mammalian DOCK180 and Drosophila Myoblast city) family (Wu and HORVITZ 1998b).
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CED-12 is the founding member of a family that includes ELMO1 (GUMIENNY et al. 2001;
Wu et al. 2001; ZHOU et al. 2001a). CED-5 and CED-12 are thought to function together to
act as an atypical guanine nucleotide exchange factor that activates Rac by exchanging GDP
for GTP (BRUGNERA et al. 2002). Finally, CED-2 is an adaptor protein containing SH2 and
SH3 domains and is most similar to mammalian CrkII (REDDIEN and HORVITZ 2000).
The involvement of CED-2 in engulfment might suggest that there is an upstream
receptor protein that becomes phosphorylated and binds the adaptor CED-2, thereby
promoting CED-2 binding to the CED-5/CED-12 guanine nucleotide exchange factor. Then,
CED-5/CED- 12 would activate CED- 10/Rac 1, which promotes cytoskeletal rearrangement.
The identity of the receptor and the signal that activate this pathway remains elusive. At one
point in my graduate studies, I attempted to knock down the function of each of a majority of
predicted C. elegans receptor tyrosine kinases using RNAi and screened for engulfment
defects. I failed to identify any dsRNAs that caused persistence of cell corpses, however, and
thus the receptor functioning in this pathway remains elusive (B. D. GALVIN and H. R.
HORVITZ unpublished observations).
The original genetic characterization of this pathway suggested that ced-10 was likely
to function only in a pathway with ced-2, -5, and -12. More recent evidence, including the
observation that over-expression of ced-10 can bypass the block in mutants defective in
either the ced-1 pathway or the ced-2 pathway but not of mutants lacking function of both
pathways, suggests that ced-10 may also act downstream of the ced-1 pathway (KINCHEN et
al. 2005). The fact that ced-10 is essential for viability of C. elegans has made genetic
analysis more difficult. Thus, most double-mutant analyses of ced-10 have been performed
using non-null alleles, limiting the conclusions that could be made. Currently there is not a
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consensus about whether or not ced-10 functions in only the ced-2 pathway or in both the
ced-1 and ced-2 pathways.
3. Other genes that have been proposed to function in the engulfment of cell corpses
Additional genes have been suggested to function in the engulfment of programmed
cell death corpses in C. elegans. These genes encode the homologs the phosphatidylserine
receptor and a member of the annexin family of proteins. These genes probably do not play a
significant role in the engulfment process, however, and have never been identified in
screens for mutations that affect engulfment. Interest in these genes began because a
hallmark uniquely present on the outer surface of the cell membranes of apoptotic corpses in
mammalian systems is phosphatidylserine (FADOK et al. 1992). For years, the correlation
between phosphatidylserine exposure and cell death has been explored in great detail. One
of the first genes identified that functions to recognize phosphatidylserine in mammalian
systems is a protein reported to function in both recognition and engulfment (FADOK et al.
2000). The protein encoded by this gene, identified by phage display, was called the
phosphatidylserine receptor. New evidence from knockout mice suggests that elimination of
this gene has no effect on corpse engulfment (BOSE et al. 2004). Additionally, recent
evidence suggests that this protein is likely to be localized to the nucleus (CIKALA et al.
2004; CUI et al. 2004). Similarly, contrary to the claims made in an initial report (WANG et
al. 2003), the C. elegans homolog of the proposed phosphatidylserine receptor, psr-1, is
unlikely to play a role in engulfment, since no persistent cell corpses are observed in animals
in which psr- 1 function has been eliminated (B. D. GALVIN and H. R. HORVITZ unpublished
observation).
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Some members of the annexin family, like the mammalian homolog of NEX-1, are
also capable of binding to phosphatidylserine. Thus there has been interest in investigating
whether C. elegans annexins affect programmed cell death. However, the gene encoding a
member of the annexin family called nex-1 is, despite a previous report (ARUR et al. 2003),
also unlikely to function in engulfment in C. elegans (D. T. HARRIS and H. R. HORVITZ
unpublished observation).
F. Additional Genes that Function in Programmed Cell Death
In addition to the genes that have been shown to function in the execution of
programmed cell death (ced-3, ced-4, ced-9, egl-1, and ced-13) and in the engulfment of cell
corpses (ced-1, ced-2, ced-5, ced-6, ced-7, ced-10, ced-12, and dyn-1), several other genes
have been shown to function in programmed cell death. These genes are described below.
1. ced-8 and ced- 11 encode proteins that are likely to function at cellular membranes
In the screen for mutant animals containing persistent cell corpses, alleles of ced-8
were isolated (ELLIS et al. 1991; STANFIELD and HORVITZ 2000). Although originally
thought to function in cell corpse engulfment, ced-8 was later shown to function in the timing
or efficient progression of cell death. In animals lacking ced-8 function, an abundance of cell
corpses are visible at a late time point at which few cell corpses are observed in wild-type
animals; this observation is most likely a result of the deaths proceeding more slowly
(STANFIELD and HORVITZ 2000). CED-8 is most similar to the putative membrane
transporter XK. The function of CED-8 remains unknown, but mutations in this gene can,
like mutations in ced-7 and other genes, promote additional survival in a weak ced-3
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background.
Another transmembrane protein whose function in programmed cell death remains
unclear is CED- 11. CED- 11 encodes a member of the TRP (transient receptor potential)
superfamily of cation channels (G. M. STANFIELD and H. R. HORVITZ, personal
communication). Members of this family of proteins have been shown to be
calcium-permeable and are involved in many processes, ranging from thermosensation to
mechanotransduction (RAMSEY et al. 2006). Loss-of-function alleles of ced-11 were
originally identified as suppressors of the persistent cell corpse phenotype of ced-5 because
they change the appearance of the corpses such that they no longer have the classic refractile
button-like appearance observed using Nomarski microscopy. This is the only gene currently
known to affect the morphology of the cell corpse.
2. Nucleases function in programmed cell death to degrade the DNA of the dying cell
The first mutation found to alter the process of programmed cell death was in the
gene nuc-1 (SULSTON 1976). In animals lacking nuc-1 function, the DNA of engulfed dead
cells is not properly degraded. nuc- encodes a protein similar to mammalian DNaseII (Wu
et al. 2000). The degradation of DNA during programmed cell death in C. elegans is less
well understood than in other systems (NAGATA 2005). One of the hallmarks of apoptotic
cells in mammalian systems is the presence of TUNEL-positive (Terminal deoxynucleotidyl
Transferase-mediated dUTP Nick End Labeling-positive) DNA in cells that have died
through a caspase-dependent process (GAVRIELI et al. 1992). In C. elegans, TUNEL-reactive
DNA can be detected in dying cells only during a brief period of time during the death
process (Wu et al. 2000). Analysis of loss-of-function alleles of nuc-1 suggests that one of
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the functions of NUC- 1 is to convert TUNEL-reactive DNA to TUNEL-negative DNA, such
that in nuc-l(l) animals, TUNEL-reactive 3' hydroxyl ends of DNA fragments accumulate
in cell corpses (Wu et al. 2000). This result suggests that at least one additional nuclease
functions upstream of NUC-1 to generate the TUNEL-reactive DNA in the first place.
NUC-1 does not function only in the degradation of DNA in programmed cell death, because
bacterial DNA in the gut also goes undigested in nuc-l (J) animals. In mammalian systems,
the NUC-1 homolog DNaseII is clearly responsible for degrading DNA from apoptotic cells,
because in DNasellI-null mice, the macrophages that engulf many apoptotic corpses contain
undigested DNA (KAWANE et al. 2003; KRIESER et al. 2002).
One of the interesting unexplored observations concerning the cell death pathway is
that, in animals lacking ced-1 and nuc-1, none of the TUNEL-reactive DNA that is normally
observed in nuc-1(l) animals can be detected (Wu et al. 2000). Loss of ced-7 also
suppresses the formation of TUNEL-reactive DNA in cell corpses, but not to the same degree
as does loss of ced-1. These results suggest that ced-1 and to a lesser extent ced- 7 are
required to activate the process that leads to the formation of TUNEL-reactive DNA. This
activity further distinguishes members of the ced- I pathway from the ced-2 pathway.
A survey of additional DNase-like genes encoded in the C. elegans genome led to the
suggestion that seven additional nucleases function in some aspects of cell corpse DNA
degradation and cell death execution (PARRISH and XUE 2003). This characterization of
nucleases was performed using RNAi and awaits further confirmation using loss-of-function
alleles. A loss-of-function allele of the gene encoding a homolog of a mitochondria
endonuclease (LI et al. 2001), which may function in mammalian apoptosis, has also been
reported to perturb DNA degradation (PARRISH et al. 2001). Although a mutation that maps
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to the general location of this gene, cps-6, has been isolated in a screen, no DNA sequence
change can be found in the genomic locus and thus further characterization of this gene is
required. The identity of the remaining critical players in DNA degradation and in particular
the nucleases that act to generate TUNEL-reactive DNA ends remains an important open
question, as no candidates have been isolated thus far in C. elegans.
3. A possible new role for mitochondria in programmed cell death in C. elegans
Recent work has focused greater attention on the role that the mitochondria play in
programmed cell death in C. elegans. Although much of the mammalian research into
programmed cell death has focused on mitochondria, until fairly recently the role of
mitochondria in cell death in C. elegans has been limited to the localization of the execution
proteins CED-9 and CED-4 (CHEN et al. 2000). In C. elegans, CED-9 is constitutively
localized to mitochondria and, in the absence of EGL-1, sequesters CED-4 to the
mitochondria and prevents it from activating CED-3. As previously discussed, although the
release of cytochrome c from mitochondria is a critical step in the activation of apoptosis in
mammals, as yet no role has been established for cytochrome c in cell death in C. elegans. In
mammals, mitochondria have been observed to fragment during apoptosis, and interference
with this process has been shown to block apoptosis (FRANK et al. 2001; KARBOWSKI and
YOULE 2003). Evidence has recently been reported that a similar phenomenon occurs in
programmed cell death in C. elegans. This mitochondrial fragmentation can be induced by
EGL-I in a CED-9-dependent fashion and requires the activity of the dynamin-related
protein DRP-1, a protein whose homologs act in mitochondrial fragmentation in mammalian
cells (JAGASIA et al. 2005). Overexpression of a dominant-negative drp-1 construct
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promotes inappropriate cell survival, whereas overexpression of wild-type drp-1 can induce
cell death. These results suggest that the mitochondria may play a significant role in
programmed cell death in C. elegans.
1II. THE REGULATION OF THE PROGRAMMED CELL DEATHS OF SPECIFIC
CELLS IN C. elegans
Although many of the core genes that function in all programmed cell deaths are
known, the regulation of this process in specific cells is less well understood. Only nine
genes that contribute to the regulation of seven programmed cell deaths have been described,
from among 152 somatic cell deaths that occur either in the male or in the hermaphrodite. In
C. elegans, the decision of a cell to live or die depends on whether it expresses egl-1. Thus,
this discussion of the regulation of cell death in C. elegans will focus on the regulation of
egl-1 transcription.
A. Four Genes Contribute to the Regulation of the Deaths of the NSM Sister Cells
Two of the 131 cells that die during hermaphrodite development are the sisters of the
serotonergic neurosecretory motor (NSM) neurons. In a screen to identify mutations that
cause the inappropriate survival of the sisters of the NSMs, alleles of two genes were
isolated. Loss-of-function mutations in ces-2 (ces, cell death specification) prevent the
deaths of the NSM sister neurons, and a gain-of-function mutation in ces-1 prevents these
deaths and the deaths of the sisters of the 12 neurons (ELLIS and HORVITZ 1991). The model
for how these genes function in wild-type animals is that CES-1 is a repressor of egl-1
transcription, and CES-2 is a repressor of ces-1 transcription (METZSTEIN et al. 1996).
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Specifically, CES-2 binds to an intronic element in ces-1 and prevents its transcription. In
ces-l(gf) mutant animals, the DNA element to which CES-2 normally binds is mutated such
that CES-2 can no longer bind and ces-1 is likely expressed. CES-1 then prevents death by
binding to a regulatory site in egl-1 and preventing its transcription (THELLMANN et al.
2003). Loss of ces-2 results in a failure to repress ces-1 expression and thus similarly
promotes survival. This model is supported by the observation that loss of ces-1 completely
suppresses the survival observed in ces-2(l) animals. The products of two other genes, hlh-2
and hlh-3 (hlh, helix loop helix), promote transcription of egl-1 in the NSM sister cells by
binding to sites that overlap with the CES-1 binding site (THELLMANN et al. 2003).
Based on the studies of ces-1 and ces-2 in C. elegans, the mammalian genes SLUG
and HLF (hepatic leukemia factor), respectively, were shown to regulate programmed cell
death in mammalian cells. HLF had been previously identified because a translocation that
causes a chimeric version of HLF fused to the E2A gene is associated with acute
lymphoblastic leukemia (HUNGER et al. 1992; INABA et al. 1992). The translocation found in
leukemic cells leads to the production of a protein that is a fusion of the DNA-binding
domain of HLF to the activation domain of E2A. This HLF-E2A chimera binds to SLUG
and activates its expression, leading to a reduction in the amount of apoptosis in developing
blood cells, and contributing to the development of leukemia (INUKAI et al. 1999). The
mechanism by which SLUG over-expression leads to a reduction in apoptosis is that SLUG
directly binds to and represses PUMA, a BH3-only gene (i.e. a homolog of egl-1 in C.
elegans) (Wu et al. 2005).
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B. Expression of and Killing by egl-1 in the HSNs is Inhibited by the Binding of TRA-1
in Hermaphrodites
The regulation of cell survival of the HSNs, two cells that die in males and survive in
the hermaphrodite, has been described (CONRADT and HORVITZ 1999). Since these cells
control egg laying, elimination of the HSNs leads to an egg-laying defect. As mentioned
above, gain-of-function alleles of egl-1 were identified in screens for animals that do not
properly lay eggs (TRENT et al. 1983). In these dominant alleles of egl-1, the binding site for
TRA-1, a protein that can function as a transcriptional repressor of egl-1 in hermaphrodites,
is mutated and prevents binding (CONRADT and HORVITZ 1999). TRA-1 (tra, sexual
transformer) is the most downstream gene product that functions in C. elegans sex
determination. TRA-1 normally binds to the site altered by these egl-1 gain-of-function
mutations and prevents transcription of egl-1 in hermaphrodite HSNs. Thus, in animals in
which the TRA-1 binding site in egl-1 has been mutated, egl-1 transcription is no longer
inhibited and the HSNs inappropriately die.
The transcriptional activators that function to promote the transcription of egl-1 in the
absence of this repression have not been conclusively identified. A screen for mutations that
suppress the death of the HSNs in egl-l(gf) hermaphrodites led to the identification of two
genes, eor-1 and eor-2, that contribute to death of the HSNs (HOEPPNER et al. 2004). EOR-1
is a putative transcription factor containing zinc finger domains, and EOR-2 is a novel
conserved protein. The protein products of these genes may directly bind and contribute to
the activation of egl-1 transcription.
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C. The Programmed Death of a Specific Ventral Cord Neuron is Controlled by the
Homeodomain Transcription Factors MAB-5 and CEH-20
The Hox genes mab-5 and ceh-20 function together to regulate the death of the
Pl 1.aaap cell (a neuron in the posterior ventral nerve cord) by binding to the egl-1 locus (Liu
et al. 2006). Loss of either mab-5 or ceh-20, which are both expressed in this cell, prevents
this death and specifically prevents egl-1 transcription. Transgenic egl-1 constructs
containing mutations that perturb the binding of MAB-5 and CEH-20 fail to rescue the
inappropriate survival of this cell in egl-1 rescue assays. This direct control of egl-1
expression by Hox genes demonstrates a direct link between these important developmental
genes and the control of programmed cell death.
D. An Evolutionarily Conserved Enhancer Element is Required for the Death of the
VC-like Neurons
In a screen to identify additional genes that regulate programmed cell death, a
non-coding mutation in egl-1 was identified. This element is specifically required for the
death of six neurons - the VC-like neurons - in the ventral nerve cord of C. elegans
hermaphrodite. The characterization of this element and the identification of proteins that
may bind to this element to regulate these deaths are presented in Chapter 3 of this thesis.
E. egl-1 Does Not Regulate Programmed Cell Death in the Germline
Although the execution genes ced-3, ced-4, and ced-9 all function in both somatic and
germline cell death, two observations suggest that programmed cell death in the germline is
regulated differently. First, a gain-of-function mutation in ced-9(n1950), which prevents the
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deaths of essentially all somatic cells programmed to die, has no affect on germ cells
(GUMIENNY et al. 1999). Second, loss of egl-1 does not promote survival in the germline
(CONRADT and HORVITZ 1998). Structural analysis of CED-9 and EGL-1 has shown that the
ced-9(n1950) mutation perturbs the ability of BH3-only proteins such as EGL-1 to interact
with CED-9 (YAN et al. 2005). What controls germline deaths upstream of ced-9 is
unknown. Although the regulation of normal death in the germline is not understood, germ
cell death in response to toxic insults such as DNA may to be regulated by several genes.
One of these genes (cep-1, which is similar to p53) may induce egl-1 transcription and death
in response to DNA damage (DERRY et al. 2001; SCHUMACHER et al. 2001). However, egl-1
does not regulate the normal programmed cell deaths that occur in the germline during
development in the absence of DNA damage.
F. The Programmed Deaths of Several Male-Specific Cells are Regulated Differently
Nearly all of the somatic programmed cell deaths that occur in C. elegans are
believed to utilize the egl-1, ced-9, ced-4, and ced-3 genes. Two cell deaths that occur in
males may be exceptions. One of these deaths appears to be determined stochastically, such
that one member of an equipotent pair of cells, B.alapaav and B.arapaav, always dies and the
other survives (SULSTON et al. 1980). Death of either B.alapaav or B.arapaav requires the
engulfment genes ced-1 and ced-2 (HEDGECOCK et al. 1983), which contribute only very
weakly to most cell deaths in C. elegans. The complete dependence of this death on
engulfment is highlighted by the fact that ablation of the P12.pa cell, which normally engulfs
the cell corpse generated in this cell death, causes this pair of cells both to survive (SULSTON
and WHITE 1980). This linkage of programmed cell death to the cell-cell signaling that must
- 38-
be occurring among these cells to ensure that only one of these two cells survives is a novel
phenomenon, and further study of these deaths might provide important insights into the
regulation of programmed cell death. Additionally, the complete dependence of this death on
engulfment should be explored.
The second of the uniquely regulated male-specific deaths occurs in the linker cell,
whose migration leads the extension of the developing gonad in the male (KIMBLE and HIRSH
1979). This cell dies by a process that morphologically resembles programmed cell death but
is not dependent on genes known to function in programmed cell death (ELLIS and HORVITZ
1986) (M. C. ABRAHAM and S. SHAHAM, unpublished observations).
IV. PATHOLOGICAL DEATHS OF SPECIFIC CELLS
In addition to the programmed cell deaths that occur during development and in the
adult germline, there are several pathologic cell deaths that occur in C. elegans as a result of
mutations in specific genes. These deaths are not a part of normal development. Most of the
mutations that cause these deaths have been isolated in screens for specific phenotypes, such
as touch-insensitivity or failure to possess a functional vulva. These deaths are described
below.
A. Channel Hyperactivation Can Cause the Necrotic Deaths of Neurons
In a screen to identify worms that were defective in the avoidance response to gentle
touch, several dominantly acting alleles of mec-4 (mec, mechanosensory abnormal), referred
to as mec-4(d), were isolated that cause the inappropriate death of six neurons (CHALFIE and
Au 1989; CHALFIE and SULSTON 1981). Similarly, an allele of the gene deg-1 (deg,
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degeneration of certain neurons) also causes neuronal death and was isolated in a screen for
animals defective in a different touch response (CHALFIE and WOLINSKY 1990). Both of
these genes encode homologs of subunits of DEG/ENaC (degenerin/epithelial Na channel)
ion channels, and gain-of-function mutations in each of these genes, which cause
inappropriate channel activity and death, affect homologous residues (CHALFIE and
WOLINSKY 1990; DRISCOLL and CHALFIE 1991). MEC-10, UNC-8, and UNC-105 are also
subunits of DEG/ENaC channels and can be mutated to cause the death of specific cells
(HUANG and CHALFIE 1994; LIU et al. 1996; TAVERNARAKIS et al. 1997).
DEG/ENaC channels are heteromeric transmembrane complexes that function in
processes ranging from sensory perception to electrolyte balance (MANO and DRISCOLL
1999). The gain-of-function mutations cause the deaths of the specific neurons in which
these channels are expressed by hyperactivating the channels and causing increased ion
influx that is ultimately toxic. Loss-of-function alleles of mec-4, deg-1, and others do not
cause cell death. Other genes can also mutate to cause necrotic deaths. For example,
gain-of-function mutations in deg-3, which encodes a subunit of a nicotinic acetylcholine
receptor, and transgenic expression of activated Gats (BERGER et al. 1998; KORSWAGEN et al.
1997), can cause deaths that are morphologically very similar to the mec-4(d) and
deg-1 (d)-induced cell deaths.
These cell deaths induced by channel hyperactivation are both genetically and
morphologically distinct from programmed cell deaths. Unlike programmed cell deaths,
which form compacted cell corpses, the neurons that die swell to several times their normal
diameter before disappearing. Ultrastructurally, electron-dense membranous whorls are
observed, followed by a swelling and degradation of organelles, distortion of the nucleus, and
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the appearance of large vacuoles (HALL et al. 1997). These deaths resemble mammalian
cellular necrosis, and for this reasons these types of channel hyperactivation-induced cell
death in C. elegans are normally referred to as being necrotic cell deaths (WALKER et al.
1988). Genetic analysis established that these deaths are independent of the canonical
programmed cell death pathway, as ced-3, ced-4, ced-9, and egl-1 are not required for these
deaths (CHUNG et al. 2000). Although mutations in the engulfment genes slow the
disappearance of the dying necrotic cells, they do not contribute to the cell-killing process in
necrotic cell death (CHUNG et al. 2000). Calcium appears to function in these necrotic
deaths, because mutations in calreticulin, which regulates intracellular calcium, and other
genes that function in calcium regulation can suppress the deaths of these cells (Xu et al.
2001). Finally, these deaths also require the activity of calcium-activated calpain proteases
and aspartyl proteases (SYNTICHAKI et al. 2002).
B. Rare Mutations in lin-24, lin-33, and pvl-5 Can Cause Pn.p Cell Death
In a screen to identify genes that affect vulval cell lineages, alleles of two genes,
lin-24 and lin-33, were identified that caused deaths morphologically distinct from both
programmed and necrotic deaths (FERGUSON and HORVITZ 1985). The mutations in lin-24
and lin-33 cause the death of the Pn.p hypodermal blast cells, three of which normally give
rise to the vulva; thus these deaths result in vulvaless animals. These deaths are
characterized in Chapter 4 of this thesis.
A mutation in the uncloned gene pvl-5 can also cause the death of the Pn.p cells
(JOSHI and EISENMANN 2004). A single allele ofpvl-5 was isolated in a screen for
abnormally shaped vulvas. The Pn.p deaths seen in pvl-5 mutants require ced-3 and ced-9
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but do not require ced-4. This unique genetic profile distinguishes these deaths from
traditional programmed cell deaths, necrotic cell deaths, and the Pn.p cell deaths observed in
lin-24 and lin-33 mutants. The authors of the pvl-5 work suggest that pvl-5 may normally
protect against ced-4-independent death in these cells.
V. PROGRAMMED CELL DEATH REGULATORY MECHANISMS DESCRIBED
IN INSECTS OR MAMMALS BUT NOT IN NEMATODES
The discoveries concerning C. elegans cell death described above have pioneered the
genetic analysis of programmed cell death and laid the foundations of much of the pathway.
Genetic, cellular, and biochemical studies of D. melanogaster and of mammalian systems
have complemented these studies (CASHIO et al. 2005; DANIAL and KORSMEYER 2004).
Three cell death regulatory mechanisms discovered in D. melanogaster and in mammalian
cells play significant roles in programmed cell death but have not been described as
functioning in C. elegans cell death. These three mechanisms are described below.
A. Receptor-mediated Caspase Activation in Mammals
Programmed cell death may be more complex in vertebrates than in C. elegans. In
addition to the larger number of genes involved in the regulation of apoptosis, caspases in
mammals can be activated by mechanisms that do not appear to function in C. elegans. For
example, mammalian caspases can be activated by transmembrane receptors. The
Fas/APO-1/CD95 receptor, a member of the tumor necrosis factor (TNF) superfamily, has a
well-characterized role in direct activation of caspases, bypassing the action of the
mammalian EGL-1, CED-9, and CED-4 homologs. In the late 1980s, two groups identified
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antibodies that could induce apoptosis of specific cells (TRAUTH et al. 1989; YONEHARA et
al. 1989). Cloning of the genes that encode the antigens of these antibodies led to the
identification of the Fas receptor and established that it was similar to the TNF receptors
(ITOH et al. 1991; OEHM et al. 1992). This discovery was significant because it had been
previously observed that adding TNF to tumors caused cell death (BEUTLER and CERAMI
1986; CARSWELL et al. 1975; OLD 1985). Soon after the cloning of the Fas receptor, the Fas
ligand was identified (SUDA et al. 1993). Around the same time, Shigekazu Nagata and
colleagues identified mutations in both Fas and the Fas ligand that could lead to
lymphoproliferative autoimmune disorders in mice (TAKAHASHI et al. 1994; WATANABE-
FUKUNAGA et al. 1992). These observations suggested an important role for Fas and
Fas-ligand in negative selection of autoreactive T cells in the thymus.
Discoveries made in many laboratories have contributed to description of the
mechanism by which Fas induces apoptosis. Activation of Fas by the Fas ligand induces
formation of the death-inducing signaling complex (DISC), the complex of proteins
consisting of Fas, an adaptor protein, and a caspase. Upon Fas ligand binding to its receptor
FADD (Fas-associated death domain containing protein), an adaptor protein, binds to the
death domain in the C-terminus of Fas and recruits one of two initiator caspases, caspase-8 or
caspase-10 (KISCHKEL et al. 1995). Upon oligomerization, caspase-8 (or caspase-10)
becomes activated by proximity-driven cleavage and then cleaves and activates caspase-3, an
effector caspase. This receptor-activated apoptotic pathway is usually referred to as the
extrinsic pathway and can activate effector caspases independently of the mitochondria and
the Bcl-2 superfamily by engaging death receptors at the cell membrane. The extrinsic
pathway can also interface with the mitochondrial, or intrinsic, pathway through
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caspase-8-mediated cleavage of Bid, a BH3-only protein. Cleavage of Bid releases tBid
(truncated Bid), which can then translocate to the mitochondria and induce the release of
cytochrome c, leading to further activation of the apoptotic pathway (LI et al. 1998).
B. Direct Activation of an Apoptotic DNase by Caspase Cleavage of its Inhibitor
Although not essential for apoptosis, the degradation in DNA of apoptotic cells is one
of the most commonly assayed markers of this process (NAGATA 2005). In mammalian cells,
DNA degradation is, in part, mediated by the caspase-activated DNase (CAD, also called
DFF40) (ENARI et al. 1998; LIU et al. 1997; SAKAHIRA et al. 1998), which does not have an
identifiable homolog in C. elegans. This DNase generates double strand breaks with a
hydroxyl group at the 3' end (WIDLAK et al. 2000). This hydroxyl group acts as a substrate
for terminal deoxynucleotidyl transferase (TdT), which is commonly used to detect apoptotic
cells in the TUNEL-labeling protocol. For CAD to be functional, it needs to be synthesized
in the presence of its partner ICAD (inhibitor of CAD), which acts as a chaperone and
ensures proper folding of CAD. ICAD also binds and inhibits the activity of mature, folded
CAD (SAKAHIRA et al. 2000). Upon activation of caspase-3, ICAD is cleaved and active
CAD is liberated to cleave chromosomal DNA in the nucleus. Although a gene encoding this
enzyme has not been found in the C. elegans genome, a DNase (like CAD) that generates
TUNEL-reactive DNA must function in programmed cell death in C. elegans, because
TUNEL-reactive DNA is generated and accumulates in animals lacking the nuclease nuc-1.
C. Inhibitors of Apoptosis (IAPs) and IAP Inhibitors Act To Regulate Cell Death in
D. melanogaster and in Mammals
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In D. melanogaster, the main mechanism by which programmed cell death is
regulated appears to be different from that found in C. elegans. Observations by Hermann
Steller and colleagues sparked extensive research into the genetic regulation of programmed
cell death in D. melanogaster. Their studies indicated that in D. melanogaster, as in C.
elegans, a large number of cells die during embryonic development. These cell deaths
ultrastructurally resembled those observed in C. elegans and in mammalian systems
(ABRAMS et al. 1993). It was found in this work that the vital die acridine orange specifically
labels apoptotic cells in D. melanogaster embryos (ABRAMS et al. 1993). The screening of a
deficiency collection for embryos that lacked acridine orange staining led to the identification
of four overlapping deficiencies that eliminated all death (WHITE et al. 1994). The
deficiencies removed three genes (Reaper, Hid, and Grim) that act in developmental deaths.
Both transcriptional and posttranscriptional regulation of Reaper, Hid, and Grim are
central to the control of apoptosis in D. melanogaster (CASHIO et al. 2005). The proteins
encoded by these genes are thought to induce death by inhibiting the function of Diap 1
(Drosophila inhibitor of apoptosis). Loss of Diap 1 causes lethality and a great increase in
apoptosis (GOYAL et al. 2000; LisI et al. 2000; WANG et al. 1999). IAPs, like Diap, bind to
the active sites of caspases and block their activity by sequestration or by promoting their
degradation (CASHIO et al. 2005). Reaper, Hid, and Grim function both by promoting IAP
degradation and by binding IAPs more efficiently than do caspases (CASHIO et al. 2005).
Mammals have proteins (namely, SMAC/DIABLO and OMI/HTRA2) that are distantly
related to and function similarly to Reaper, Hid, and Grim, and these proteins may be
important activators of apoptosis in mammals (VAUX and SILKE 2003).
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VI. CONCLUSION
In C. elegans, the major determinant of whether most cells will undergo programmed
cell death is whether or not egl-1 is expressed. If egl-1 is expressed, it inhibits the
anti-apoptotic function of CED-9, releasing the adaptor protein CED-4 to activate the caspase
CED-3. Mammalian systems possess homologs of EGL-1, CED-9, CED-4, and CED-3, and
the genetic and molecular interactions between the components have important similarities to
those found in C. elegans. However, mammalian systems also have pathways that activate
caspases directly, by bypassing activities similar to those provided in C. elegans by egl-1 and
ced-9. One such pathway is the Fas/Fas ligand pathway, described above. This Fas/Fas
ligand system is specific to mammals; D. melanogaster does not seem to have any clear
homologs of Fas, and although it does possess homologs of CED-9, CED-4, and CED-3, it
does not appear to have BH3-only proteins similar to EGL- 1. Thus, the decision of cells to
undergo programmed cell death in D. melanogaster is based neither on expression of an
EGL- 1-like protein nor on the activity of a Fas-like pathway, but instead on expression of the
IAP regulators, Reaper, Hid, and Grim. Although IAP homologs exist in C. elegans and in
mammals, they do not play an obvious role in programmed cell death in C. elegans (FRASER
et al. 1999; SPELIOTES et al. 2000) (E. K. SPELIOTES and H. R. HORVITZ unpublished
observations) and the role they play in mammalian apoptosis is unclear (VAUX and SILKE
2003).
Although the details of upstream regulation may differ among C. elegans,
D. melanogaster, and mammals, the regulation of programmed cell death in all systems
comes down to the activation of caspases. In general, especially in C. elegans and mammals,
a single conserved mechanism is used to directly regulate this process: an adapter protein
-46 -
forms a platform that can bind caspases and activate them. These platforms can be
assembled in different ways, but they all accomplish the same task: bringing pro-caspase
molecules close together such that they cleave and activate one another. The conservation of
the proteins and the fact that critical discoveries have been made in each system highlights
the importance of these parallel investigations. From future studies in each of these systems,
we will continue to identify the critical mechanisms for the regulation of apoptosis.
Ultimately, therapeutic interventions may be available to correct the negative consequences
that can result from the misregulation of this pathway.
In my thesis work, I have investigated the mechanisms of regulation of cell death in
C. elegans, building on the work described in this introduction. In the following chapters, I
describe some of the experiments I have performed. In Chapter 2, I present the
characterization of a regulator of ced-4 splicing isolated in a screen to identify genes that
function in programmed cell death. In Chapter 3, I discuss the identification of a
tissue-specific enhancer element in egl-1 and a novel transcription factor that may bind to
this element and activate egl-1 transcription in a specific subset of cells. In Chapter 4, I
describe my work characterizing a cytotoxic cell death process that is induced by mutations
in two genes and requires engulfment genes, but is distinct from programmed cell death.
-47 -
FIGURE LEGENDS
Figure 1. A molecular genetic pathway for the genes controlling programmed cell death in
C. elegans.
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Chapter Two
The SR Protein Kinase spk-1 Regulates Programmed Cell Death in C. elegans
by Controlling the Alternative Splicing of ced-4 RNA
Brendan D. Galvin and H. Robert Horvitz
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SUMMARY
To identify additional genes involved in programmed cell death in C. elegans, we
performed a genetic screen to isolate mutations that cause an increase in the number of
programmed cell deaths. We screened for suppressors of the cell-death defect due to a partial
loss-of-function mutation in ced-4, which encodes an essential regulator of programmed cell
death that promotes death by activating the caspase CED-3. We identified one ced-4
suppressor, which had a mutation in the gene spk-1. The spk-1 gene encodes a protein that is
homologous to SR protein kinases, which are thought to regulate splicing. Previous work
suggests that ced-4 can be alternatively spliced and that the splice variants function
oppositely, with the longer transcript (ced-4L) inhibiting programmed cell death. spk-1
appears to promote cell survival by increasing the amount of the protective ced-4L splice
variant. We conclude that programmed cell death in C. elegans is regulated by an alternative
splicing event that is controlled by an SR protein kinase.
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INTRODUCTION
Multicellular organisms can eliminate cells by a process known as programmed cell
death or apoptosis. Apoptosis plays a fundamental role in development and in tissue
homeostasis and human health (FADEEL and ORRENIUS 2005; MEIER et al. 2000). Notably,
improper control of apoptosis is associated with disease. Defects in apoptosis that cause
either too much death or too little have been implicated in cancers, neurodegenerative
diseases, and autoimmune diseases (FADEEL and ORRENIUS 2005).
During the development of the C. elegans hermaphrodite, 1,090 somatic cells are
generated by an essentially invariant pattern of divisions (KIMBLE and HIRSH 1979; SULSTON
and HORVITZ 1977; SULSTON et al. 1983). Of these cells, 131 undergo programmed cell
death (SULSTON and HORVITZ 1977; SULSTON et al. 1983). At least 20 genes have been
identified that regulate either the pattern or the process of programmed cell death in
C. elegans (LETTRE and HENGARTNER 2006). The core pathway of programmed cell death in
C. elegans is composed of four genes: egl-1, ced-9, ced-4, and ced-3. The cloning of these
four genes defined a molecular pathway for programmed cell death later shown to be
conserved in vertebrates (CONRADT and HORVITZ 1998; HENGARTNER et al. 1992;
METZSTEIN et al. 1998; YUAN and HORVITZ 1992; YUAN et al. 1993).
CED-3 is a defining member of the caspase (cysteine aspartate-specific protease)
family (YUAN et al. 1993). The identification of ced-3 as encoding a protease led to the
discovery that caspases are required for many apoptotic cell deaths in mammals (DEGTEREV
et al. 2003). ced-4 encodes a protein similar to Apaf- 1 (apoptotic protease activating factor)
(YUAN and HORVITZ 1992; Zou et al. 1997), which facilitates CED-3 activation
(CHINNAIYAN et al. 1997; SESHAGIRI and MILLER 1997; WU et al. 1997; YANG et al. 1998).
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Cells are protected from programmed cell death by ced-9 (HENGARTNER et al. 1992), which
encodes a member of the Bcl-2 family of apoptotic regulators (HENGARTNER and HORVITZ
1994b). Human BCL-2 can block programmed cell death in C. elegans and can substitute for
ced-9, demonstrating a functional conservation (HENGARTNER and HORVITZ 1994b; VAUX et
al. 1992). Finally, egl-1 encodes a BH3-only protein (defined as a Bcl-2 family member
lacking obvious BHI, BH2, and BH4 domains) that negatively regulates CED-9 in dying
cells (CONRADT and HORVITZ 1998). Transcriptional control of egl-1 is likely to be the
major mechanism of the regulation of programmed cell death (CONRADT and HORVITZ 1998).
egl-1, ced-9, ced-4, and ced-3 act within dying cells to control all somatic programmed cell
deaths in C. elegans (CONRADT and HORVITZ 1998; YUAN and HORVITZ 1990);
loss-of-function mutations in egl-1, ced-4, or ced-3 or a gain-of-function mutation in ced-9
prevent essentially all somatic programmed cell deaths (CONRADT and HORVITZ 1998; ELLIS
and HORVITZ 1991; HENGARTNER et al. 1992).
ced-4 encodes two transcripts, ced-4L and ced-4S, that appear to have opposing
functions (SHAHAM and HORVITZ 1996). Whereas ced-4S (the predominant transcript)
promotes cell death, ced-4L protects cells from death. The observation that ced-4 has two
functionally different splice variants originated from the identification of a DNA element in
the ced-4 genomic locus that was not contained within the originally described ced-4 cDNA.
This element was highly conserved in two Caenorhabditis species, C. briggsae and C.
vulgaris, that are distant relatives of C. elegans (SHAHAM and HORVITZ 1996). This
conservation is significant because only the coding regions and key regulatory elements are
likely conserved between these Caenorhabditis species. Further studies confirmed that this
element was part of an alternative cDNA that encodes a protein that can protect cells against
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death. The function of CED-4L was determined by overexpressing this protein in C. elegans
and observing that, unlike CED-4S, CED-4L protects cells against programmed cell death
(SHAHAM and HORVITZ 1996). Recent structural work suggests that CED-4L prevents the
formation of the CED-4 tetramer, which is required for activation of CED-3 and the initiation
of programmed cell death (YAN et al. 2005).
Approximately 2,500 genes in C. elegans (about 13% of the genes currently
annotated in Wormbase (http://www.wormbase.org/)), are predicted to be alternatively
spliced (ZAHLER 2005). Splicing is a highly regulated process that removes intronic
fragments of RNA from newly transcribed pre-mRNA molecules. The spliceosome, which is
composed of' small nuclear ribonucleoprotein particles (snRNPs) and proteins, is the complex
responsible for splicing (NILSEN 2003). Two families of proteins that assist the spliceosome
in splice-site selection are the heteronuclear ribonucleoproteins (hnRNPs) and the
serine-arginine-rich proteins (SR proteins) (BLACK 2003). These proteins are thought to
function oppositely; SR proteins bind to exonic splicing enhancer elements and promote the
inclusion of exons, whereas hnRNPs bind to exonic splicing silencer elements and suppress
the inclusion of exons. The SR proteins are likely regulated by the phosphorylation of
serines in the SR domains, which are thought to regulate function by modifying
protein-protein interactions (SANFORD et al. 2005). SR proteins are required for splicing in
cellular extracts and might need to be phosphorylated to function (SANFORD et al. 2005). In
this study, we describe a role for an SR protein kinase in the alternative splicing of ced-4
RNA and the regulation of programmed cell death.
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RESULTS
A Screen for Genes that Function to Prevent Programmed Cell Death
The study of programmed cell death in C. elegans has primarily focused on isolating
two types of mutants: those with extra cells and those with either abnormal or persistent cell
corpses. To identify genes that protect cells from undergoing programmed cell death, we
screened for mutations that increase the number of programmed cell deaths. Specifically, we
performed a modifier screen for mutations that suppressed the cell-death defect that is
observed in animals with a loss-of-function mutation in ced-4. To assay cell death, we
examined the ventral nerve cord. During development, 13 neuroblasts -- W, and P1-P 12 --
together generate 10 cells that undergo programmed cell death (SULSTON and HORVITZ
1977). We used worms expressing the lin-11::gfp reporter nlsl06 to visualize a subset of
these deaths: the Pn.aap cells (the posterior daughter of the anterior daughter of the anterior
daughter of one of 12 P blast cells) (REDDIEN et al. 2001). In the ventral cord of wild-type
animals, six Pn.aap cells survive and express gfp, whereas the other six undergo programmed
cell death (the two anterior-most, Pl.aap and P2.aap, and the four posterior-most,
P9-P12.aap) (SULSTON and HORVITZ 1977). By contrast, in mutants defective in cell death,
such as animals with strong loss-of-function mutations in ced-3, five extra Pn.aap cells
survive and reliably express gfp, generating a total of eleven GFP-positive cells. The most
anterior cell, P 1.aap, does not always express gfp and is thus not scored in this assay
(REDDIEN et al. 2001). The survival of Pn.aap cells can be easily monitored in strains
carrying the lin-11 ::gfp reporter using a fluorescence-equipped dissecting microscope.
To facilitate the isolation of mutations with subtle effects on programmed cell death,
we screened for mutations that cause an increase in programmed cell death in a sensitized
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genetic background. Worms containing a non-null allele of ced-4, such as n3158, are
partially defective in programmed cell death. The n3158 mutation is an early missense
mutation that changes serine 163 to phenylalanine (B. M. HERSH and H. R. HORVITZ,
personal communication). These animals on average have 4.9 extra GFP-positive Pn.aap
cells. Although n3158 thus strongly prevents the programmed cell deaths of the Pn.aap cells,
it is an allele of medium strength when assayed for survival of cells fated to die in the
anterior pharynx, an independent quantitative assay for programmed cell death
(HENGARTNER et al. 1992). ced-4(n3158) animals have an average of 6.0 extra cells in the
anterior pharynx, whereas animals carrying a null allele of ced-4 have an average of 12.8
extra cells (B. M. HERSH and H. R. HORVITZ, personal communication).
Using the lin-11::gfp reporter, we screened for suppressors of the partial
loss-of-function ced-4(n3158) mutant by looking for mutants with a reduced number of
GFP-positive Pn.aap cells (i.e., fewer than eleven) (Figure 1). The screen was performed
such that mutations in essential genes could be isolated, because mutations that increase
programmed cell death might not produce viable progeny. For example, ced-9, which is
known to protect against cell death, is an essential gene (HENGARTNER et al. 1992).
Specifically, we saved siblings of each screen isolate such that animals heterozygous for
mutations in an essential gene would be maintained. From a screen of 5,000 mutagenized
haploid genomes, one strong suppressor, n3418, was isolated. In addition to recessively
reducing the number of GFP-positive Pn.aap cells in the ced-4(n3158) background, this
mutation caused recessive sterility. The decrease in the number of GFP-positive cells in the
ced-4(n3158) n3418 double mutant was not a consequence of a defect in the generation of
the Pn.aap cells, since the GFP-positive cells were present in n3418; ced-3(null) animals
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(data not shown). This observation indicates that P2.aap and P9-P12.aap are generated
normally but are more likely to undergo programmed cell death in the ced-4(n3158) n3418
strain than in ced-4(n3158) animals. The ced-3 null allele failed to suppress the sterility
conferred by n3418, suggesting the sterility was not caused by excessive programmed cell
death (data not shown).
n3418 Is a Loss-of-Function Allele of spk-1, Which Encodes an SR Protein Kinase
Using a combination of visible phenotypic markers, deficiencies, and polymorphisms,
we mapped our suppressor mutation n3418 to a 90 kb region on linkage group III that
contains 24 genes (Figure 2A). We found that both a deletion allele of and injection of
dsRNA directed against one of theses genes, spk-1 (KUROYANAGI et al. 2000), caused a
sterility resembling that of the ced-4(n3158) suppressor n3418. We identified a mutation that
changes the codon for tryptophan 142 (TGG) to an opal stop codon (TGA) in spk-1 in n3418
mutant animals (Figure 2B). A deletion allele of spk-1, ok706, failed to complement the
sterility of n3418 (data not shown). Based on these observations, we concluded that the
sterility of n3418 was caused by the mutation in spk-1. To determine if loss of spk-1 function
also suppressed the defect in programmed cell death caused by ced-4(n3158), we tested the
effect of the spk-1(ok706A) deletion allele in ced-4(n3158) animals. spk-1(ok706A) caused
suppression of the cell-death defect in ced-4(n3158) animals to a similar extent as did
spk-1(n3418) (Table 1). Together, these results indicate that both the suppression of
ced-4(n3158) and the sterility are caused by n3418, a loss-of-function mutation in spk-1.
spk-1 encodes an SR protein kinase (Figure 2B). The SR protein kinase family
regulates alternative splicing by phosphorylating SR proteins, which are thought to be key
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regulators of splicing (BLACK 2003). In animals carrying only a loss-of-function allele of
spk-1, either n3418 or ok706A, the wild-type number of Pn.aap cells was observed (Table 1),
showing that loss of spk-1 does not cause ectopic Pn.aap programmed cell death in these
cells.
spk-1(n3418) Strongly Suppresses Partial Loss-of-Function Alleles of ced-4
To determine if the loss of spk-1 function specifically increased death in strains
homozygous for the allele ced-4(n3158), we tested the ability of spk-1(n3418) to suppress
additional alleles of ced-4 (Table 2). spk-1(n3418) also suppressed the cell-death defect of
animals carrying ced-4(n3141), which is a slightly weaker allele than ced-4(n3158), the allele
used in our screen. The allele n3141 is a missense mutation that changes arginine 53 to
lysine (B. M. HERSH and H. R. HORVITZ, personal communication). Thus, spk-1(n3418)
suppressed two partial loss-of-function alleles of ced-4. However, spk-1(n3418) did not
suppress ced-4 null alleles. Specifically, spk-1(n3418) failed to suppress either the strong
missense allele ced-4(n3040) or the early nonsense allele ced-4(nl 162), both of which cause
the complete survival of the Pn.aap cells and of all the cells that normally die in the anterior
pharynx (B. M. HERSH and H. R. HORVITZ, personal communication).
To determine if suppression by spk-1 was specific to the ced-4 gene, we tested the
ability of spk-.1(n3418) to suppress alleles of three other genes that function in the killing step
of programmed cell death. We assayed ced-3, ced-9, and egl-1 alleles that cause a cell-death
defect similar in strength to that caused by ced-4(n3158) and ced-4(n3141) in the Pn.aap
cells. We observed that spk-l(n3418) can weakly suppress the cell-death defect observed in
strains homozygous for alleles of ced-9, or ced-3, but not to the same extent as observed in
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ced-4 strains (Table 3). Even the ced-3 allele n2427, which show the strongest interaction
with spk-1(n3418) of the non-ced-4 alleles, is only moderately suppressed by spk-1. Thus,
spk-1(n3418) most strongly modifies the cell-death defect of partial loss-of-function alleles
of ced-4.
spk-1 Regulates the Alternative Splicing of ced-4
Since spk-1 most strongly suppresses ced-4, we hypothesized that spk-1 may have a
specific interaction with ced-4. This hypothesis is attractive given that SR protein kinases
are thought to regulate alternative splicing and ced-4 is the only cell death-gene known to be
regulated by alternative splicing in C. elegans (BLACK 2003; SHAHAM and HORVITZ 1996).
ced-4 encodes two different transcripts; the shorter ced-4 splice product, ced-4S, is thought to
function in promoting programmed cell death, whereas the longer product, ced-4L, is thought
to inhibit programmed cell death (SHAHAM and HORVITZ 1996).
To test directly if spk-1 (ok706A) modifies the splicing of ced-4, we performed
semi-quantitative RT-PCR of ced-4 using RNA from wild-type and homozygous
spk-1(ok706A) animals. Specifically, a primer set that amplifies both the long and short
splice forms of ced-4 was used to detect ced-4 transcripts. We observed that animals lacking
spk-1 showed a decreased amount of the ced-4L product (Figure 3). Given the anti-apoptotic
role of CED-4L, the loss of spk-1 should lead to an increased level of cell death through the
loss of the protective ced-4L transcript, as we observed. This is consistent with the
observation that animals lacking spk-1 have increased death in animals containing partial
loss-of-function alleles of ced-4.
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DISCUSSION
From a genetic screen to identify additional regulators of programmed cell death in C.
elegans, we isolated a mutation in the splicing regulator spk-1, which encodes an SR protein
kinase. Loss-of-function alleles of spk-1 increase the amount of death that occurs in strains
containing partial loss-of-function alleles of ced-4 and might also weakly increase death in
animals with mutations in ced-3 or ced-9. The increase in death correlates with a decrease in
expression of the ced-4L transcript in spk-1 null animals. Previous analysis of the function of
ced-4L relied largely on overexpression studies, whereas the data presented in this chapter
suggest that the alteration of the endogenous levels of ced-4L can directly alter the amount of
programmed cell death. We conclude that, in C. elegans, an SR protein kinase regulates the
splicing of ced-4. We propose that the regulation of ced-4 splicing plays a role in the control
of programmed cell death.
Given our genetic and molecular data, we suggest a model in which SPK-1 normally
promotes the generation of ced-4L transcripts that protect cells from dying (Figure 4). The
loss of spk-1 decreases the level of ced-4L, thereby increasing the likelihood that cells will
die. We suggest that SPK-1 controls the splicing of the fourth exon in ced-4 by regulating
the phosphorylation of an SR protein.
Although there is increased death in the spk-l(lj ced-4(l) animals, we have not
observed ectopic deaths in spk-1 null animals in otherwise wild-type backgrounds. One
possible explanation is that the regulation of ced-4 splicing is a minor determinant of whether
cells live or die. The pathway for programmed cell death in C. elegans generally has been
described as linear, with EGL- 1 promoting death by inhibiting the function of CED-9
(CONRADT and HORVITZ 1998). In the absence of EGL-1, CED-9 prevents CED-4 activation
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of the caspase CED-3 (METZSTEIN et al. 1998). It has been observed, however, that in
ced-9(null); ced-3 partial loss-of-function animals, cell death occurs in a relatively normal
pattern (HENGARTNER and HORVITZ 1994a). A linear model in which EGL-1 functions
through CED-9 would predict that in the absence of CED-9, cell death dependent on EGL-1
expression would not occur normally. However, this result shows that there must be
additional mechanisms that regulate programmed cell death independently of egl-1. Perhaps
the alternative splicing of ced-4 is one such mechanism that contributes to the decision of
which cells live or die, but in a wild-type animal, this contribution cannot be detected. In
sensitized cells, such as those that usually die but survive because of a partial loss of ced-4
function, mechanisms that can influence whether cells live or die are exposed. For example,
the promotion of cell killing by genes involved in cell-corpse engulfment is best observed in
a sensitized background containing a partial loss-of-function allele of ced-3 (REDDIEN and
HORVITZ 2004).
spk-1 is likely required for embryonic development in C. elegans, given that RNAi
with a high concentration of spk-1 dsRNA causes embryonic lethality (KUROYANAGI et al.
2000). If so, why are spk-1 null homozygotes viable and sterile? We suggest that these
animals are sustained by the SPK-1 provided by their heterozygous mothers. The maternal
stores of SPK- 1 might be depleted by late development when the deaths of the Pn.aap cells
occur. Of the 131 programmed cell deaths, 113 occur before hatching; of the remaining 18,
many occur before those of the Pn.aap cells, which die at the end of the first or beginning of
the second larval stages (SULSTON and HORVITZ 1977; SULSTON et al. 1983). Thus, it may
be that the effect that spk-1 has on increasing death in ced-4 loss-of-function animals would
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not be observed if we assayed the cell death of most other cells, which die before hatching
and possibly before the maternal stores of SPK-1 are depleted.
We believe that neither the sterility caused by spk-1 alleles nor the lethality caused by
spk-1 dsRNA is a consequence of inappropriately increased cell death, as spk-1; ced-3(null)
doubly mutant animals, in which no cell death has been observed, are still sterile. Thus,
spk- 1 seems to be essential for additional processes. SPK- 1 is the only protein found in C
elegans that is highly similar to mammalian SR protein kinases. SPK- 1 can phosphorylate
the SR domain of a C elegans SR protein in vitro (KUROYANAGI et al. 2000). There are
eight genes that might encode SR proteins in C elegans. Treatment with dsRNA directed
against individual SR genes does not result in an abnormal phenotype, except for rsp-3 (SR
protein), which causes embryonic lethality (KAWANO et al. 2000; LONGMAN et al. 2000;
LONGMAN et al. 2001). However, treatment with dsRNA directed against specific
combinations of SR genes results in sick or dead worms (KAWANO et al. 2000; LONGMAN et
al. 2000; LONGMAN et al. 2001).
To date, spk-1 and the Drosophila kinase Doa are the only genetically characterized
SR protein kinase genes for which mutations have been isolated and shown to affect levels of
different splice isoforms of target transcripts. Our work shows that, in C elegans, the SR
protein kinase SPK- 1 controls the alternative splicing of ced-4. Previous work in Drosophila
melanogaster has shown that the Clk/Sty protein kinase Doa controls the alternative splicing
of dsx (doublesex), which regulates sex determination (Du et al. 1998). Clk/Sty kinases are
distinct from SR protein kinases like SPK-1, but they do also phosphorylate SR proteins.
Reducing the function of Doa alters the splicing of dsx such that both male and
female-specific dsx mRNAs are produced in female flies (Du et al. 1998). This
- 76 -
misregulation of splicing correlates with a reduction in the level of phosphorylation of RBP 1,
an SR protein that likely functions in sex determination (DU et al. 1998).
ced-4 is the only gene in C. elegans thought to produce alternative splice variants
with opposing roles in programmed cell death (SHAHAM and HORVITZ 1996). In mammals,
however, alternative splice forms have been described for many regulators of apoptosis,
although the functional significance of these isoforms remains largely unknown (SCHWERK
and SCHULZE-OSTHOFF 2005). For example, the gene caspase-2/Ich-1, a homolog of the C.
elegans gene ced-3, produces functionally distinct alternative splice variants (WANG et al.
1994). The long caspase-2 transcript promotes apoptosis, whereas the short transcript
protects cells from death. Like that of C. elegans ced-4, the alternative splicing of
mammalian caspase-2 is influenced by SR proteins and/or SR protein kinases. Studies in
tissue culture of a caspase-2 minigene, a plasmid construct consisting of a small portion of
the genomic locus surrounding the introns of interest, suggest that overexpression of the SR
proteins SC35 and ASF/SF2 promotes the skipping of a specific exon and the generation of
the proapoptotic isoform caspase-2L (JIANG et al. 1998). Conversely, overexpression of
hnRNP (heteronuclear ribonucleoprotein) Al promotes inclusion of this exon and the
generation of a transcript consistent with the anti-apoptotic caspase-2S isoform (JIANG et al.
1998).
Whereas these studies of caspase-2 do present evidence that SR proteins regulate the
alternative splicing of programmed cell death genes, they contradict the established roles of
SR proteins and hnRNPs in the promotion of exonic inclusion and exclusion, respectively.
As described in the introduction, SR proteins normally promote inclusion of exons, whereas
hnRNPs play the opposite role. One explanation for this discrepancy might be that SR
- 77 -
proteins are not properly regulated by phosphorylation when they are overexpressed, as they
were in the caspase-2 studies. The genetic studies of Doa in Drosophila suggest that
phosphorylated SR proteins promote the inclusion of exons (Du et al. 1998). If we assume
that SPK-1 phosphorylates SR proteins in C. elegans in vivo as it does in vitro (KUROYANAGI
et al. 2000), then our results are consistent with the Drosophila findings that suggest the
phosphorylation of SR proteins promotes the inclusion of exons. When spk-1 is deleted from
C. elegans, the incorporation of the ced-4L exon decreases, just as, in Drosophila when Doa
function is reduced, the levels of incorporation of the female-specific exon of dsx decrease.
Although caspase-2 is the only mammalian cell death gene whose alternative splicing
has been shown to be influenced by SR proteins, certainly many other mammalian genes
involved in programmed cell death are alternatively spliced. For example bcl-x, which
encodes a protein homologous to CED-9, is generated from a long splice isoform, Bcl-xL,
which inhibits apoptosis and contains all four of the BH domains found in Bcl-2 (BOISE et al.
1993). The protein generated from the shorter isoform, Bcl-xs, promotes apoptosis and
contains only the BH3 and BH4 domains (BOISE et al. 1993). Consistent with their proposed
functions, Bcl-xs protein and mRNA are widely expressed and found in tissues that contain
cells undergoing apoptosis (BOISE et al. 1993; KRAJEWSKI et al. 1994).
Although many alternative splice forms of mammalian genes such as bcl-x and
caspase-2 that function in apoptosis have been described, little is known about the functions
of the alternative splice forms and the mechanisms that regulate the splice site selection of
these genes (SCHWERK and SCHULZE-OSTHOFF 2005). Our studies in C. elegans establish a
robust assay in a genetically tractable system for further investigations into how alternative
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splicing is regulated in general, and how in particular alternative splicing interfaces with
programmed cell death.
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FUTURE DIRECTIONS
The most important question that arises from the identification of SPK- I1 as a
modifier of ced-4 RNA splicing is how it functions. Previous work suggests that SR protein
kinases regulate splicing by phosphorylating SR proteins. I am currently in the process of
obtaining deletion alleles for each of the eight SR proteins found in the C. elegans genome.
Each of these deletion alleles will be tested for the ability to suppress the cell-death defect of
ced-4(n3158) animals. Determining genetically if a specific SR protein is responsible for
regulating splicing of ced-4 would be important.
Although isolation of large amounts of RNA from spk-1(A) animals remains a
technical challenge because loss-of-function alleles of spk-1 confer sterility, I would like to
confirm the observations made by RT-PCR using an assay that does not depend upon PCR
amplification, such as RNase protection. Additionally, I have generated a CED-4L-specific
antibody that might allow me to directly determine if spk-1 alleles result in a corresponding
change of the amount of CED-4L protein.
I would also like to assay the role spk-1 plays in cell deaths other than those of the
specific cells I assayed in this work. Since maternal rescue may preclude the analysis of
early developmental deaths, late developmental deaths, such as those that occur in the male
tail, might be the best cells to assay.
Finally, it would be interesting to modify the ced-4 genomic locus by homolgous
recombination to make targeted changes to test the function of various portions of the
genomic locus. Although no robust system is currently available for homologous
recombination in C. elegans, when it is, these critical experiments need to be performed. I
have spent several months attempting to modify the genomic locus without success.
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EXPERIMENTAL PROCEDURES
Strains and General Techniques
Strains were cultured as described by BRENNER (1974) and grown at 200 C. The
Bristol strain N2 was used as the wild-type strain, except in multifactor mapping experiments
that used the polymorphic wild-type strain CB4856 (WICKS et al. 2001). The mutations used
are listed below, and are description by RIDDLE (1997) unless otherwise indicated:
LGIII: ced-4(n3158) (S. CAMERON and H. R. HORVITZ, unpublished), ced-4(n3141) (G.
M. STANFIELD and H. R. HORVITZ, unpublished), ced-4(n1162), ced-4(n3040) (E. K.
SPELIOTES and H. R. HORVITZ, unpublished), spk-1(n3418) (this study), spk-1(ok706) (C.
elegans Gene Knockout Consortium), lon-1(e185), ced-9(n3377) (P. W. REDDIEN and H.
R. HORVITZ, unpublished)
LGIV: ced-3(n717), ced-3(n2427, n2436) (HENGARTNER and HORVITZ 1994a)
LGV: egl-1(n3331) (REDDIEN et al. 2001), egl-1(n4045) (B. D. GALVIN and H. R.
HORVITZ, unpublished), nIs96(lin-ll1::gfp) (REDDIEN et al. 2001)
LGX: nls 06(lin-11::gfp) (REDDIEN et al. 2001)
The translocation hT2 containing the integrated transgene qls48 was also used
(WANG and KIMBLE 2001).
Screen for Suppressors of ced-4(n3158)
We mutagenized L4 ced-4(n3158); nls106 hermaphrodites with ethyl
methanesulfonate (EMS) as described by BRENNER (1974). After allowing the animals to
recover, Pos were transferred one per 5 cm plate. After 3-5 days, 12 F , L4 hermaphrodites
were individually transferred to 5 cm plates, and F2 animals on these plates were
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subsequently screened for animals with the wild-type number of GFP-positive Pn.aap cells.
We screened the progeny of 2500 F1 animals. Six siblings were picked from any plate on
which a suppressor was isolated to ensure that heterozygous siblings were maintained for
isolates that were inviable.
Quantitation of Cell Death in the VC-like neurons and the Anterior Pharynx
Pn.aap cells expressing GFP were visualized using a dissecting microscope equipped
with fluorescence optics (M2BIO, Kramer Scientific, Valley Cottage, NY). Animals late in
the fourth larval stage were picked using a standard dissecting microscope and transferred to
the fluorescence-equipped dissecting microscope for counting of their surviving VC-like
neurons.
Cloning of spk-1
Using standard deficiency and mapping techniques, we placed the n3418 mutation
between a polymorphism on cosmid F54C8 (snp_F54C8[1]) and a polymorphism on
ZK1098 (snp ZK1098[1]) that exists between C. elegans strains N2 and CB4856.
Determination of Mutant Allele Sequences
We used PCR-amplified regions of genomic DNA to determine mutant sequences.
For spk-1(n3418) we determined the sequence of all exons and splice junctions. Sequences
were determined using an ABI Prism 3100 Genetic Analyzer.
Semi-Quantitative RT-PCR Analysis of ced-4 Transcripts
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Sixty-six 9-cm plates of spk-1(ok706A)/hT2[qls48] animals were washed into 1 L of
liquid growth media. The culture was grown until saturated with gravid adults and harvested
prior to starvation or the appearance of dauer larvae. Worms were bleached to collect
embryos. The embryos were allowed to hatch for 12 hours in 500 mL of liquid growth media
and sorted for non-GFP-positive worms for 4 hours using a COPAS BioSort instrument
(Union Biometrica, Holliston, MA) according to manufacturer's instructions. Worms were
collected in batches of 50,000 and concentrated by centrifugation. The young larva were
flash frozen in liquid nitrogen and stored at -800 C in Trizol (Invitrogen, Carlsbad, CA).
The same procedure was performed on the N2 control, strain except the 1 liter culture was
started from six 9 cm plates. RNA was isolated from the animals as previously described
(PORTMAN 2006), except smaller volumes were used. The purified RNA was DNase treated
using amplification grade Deoxyribonuclease I (Invitrogen, Carlsbad, CA) according to the
manufacturer's instructions. RT reactions were performed with random hexamers according
to the manufacturer's instructions for use with SuperScript III First strand Synthesis System
for RT-PCR (Invitrogen, Carlsbad, CA). Dilutions of RT-reaction were performed to
establish a linear range for semi-quantitative PCR reactions. The sequences of the ced-4
primers are 5'-ACCTTGCTGATTTCCTCGAA-3' and
5'-AATGAAGTCGGTGATCGAATG-3', and for the loading control ama-1 (which encodes
the large subunit of RNA polymerase II) they are 5'-GATCAGGCGACCTATTTGGA-3' and
5'-TGGAAGAAGAATTCCGATGG-3'.
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FIGURE LEGENDS
Figure 1: Screen to Identify Genes that Protect Against Programmed Cell Death
After mutagenizing ced-4(n3158); nIsl06 animals with EMS, we used fluorescence
microscopy to examine F2 individuals for a decreased number of GFP-positive cells.
Figure 2: Molecular Identification of the ced-4(n3158) Suppressor spk-1(n3418)
(A) Schematic representation of the physical map of the spk-1(n3418) region and the gene
structure of spk-1 showing the location of the allele n3418 and the deletion allele ok706A.
The interval to which spk-1(n3418) was mapped contained 24 genes. RNAi against one
gene, B0464.5, in the interval caused a sterility that resembled that of spk-1(n3418)
(KUROYANAGI et al. 2000). Sequence analysis and genetic tests with the deletion allele
spk-1(ok706) showed that this identified nonsense mutation caused the observed phenotype.
(B) SPK-1 is similar to mammalian SR Protein Kinases. Human SRPK1 and SRPK2 are
compared to SPK-1. The numbers indicate amino acid positions. The red asterisk indicates
the location of the n3418 mutation, which changes tryptophan 142 to a opal stop codon.
Figure 3: spk-1 Promotes Generation of the Protective ced-4L Transcript
This agarose gel stained with ethidium bromide shows products generated by PCR using
primers flanking the first three introns of ced-4 and the sixth intron of the control ama-1 from
wild-type and spk-1(ok706A) RNA, labeled + and A respectively at the bottom of the gel (see
Experimental Procedures for details). The ama-1 band in the spk-1(ok706A) is smeared due
to an impurity in the gel. 1 kb Plus DNA Ladder (Invitrogen, Carlsbad, CA) was run in the
first and sixth lanes and the 200, 300, 400, and 500 base-pair bands are labeled.
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Figure 4: Model for the Regulation of ced-4 RNA Splicing and Programmed Cell Death
by SPK-1
(A) In wild-type animals SPK- 1 promotes the generation of the protective ced-4L
alternative splice variant, which protects against programmed cell death. Loss of SPK- 1
decreases the production of ced-4L, thereby decreasing protection against programmed cell
death.
(B) SPK-1 might promote the use of the ced-4L splice site in the ced-4 pre-mRNA by
phosphorylating an SR protein.
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Table 1. Loss-of-function Alleles of spk-1 Suppress the
Survival of Extra Pn.aap Cells in ced-4(n3158) Animals
No. extra
Genotypea Pn.aap cells ± SE (n)
Wild type 0 (109)
ced-4(n3158) 4.9 ± 0.04 (50)
ced-4(n3158) spk-1(n3418) 2.0 + 0.1 (71)
ced-4(n3158) spk-l(ok706A) 1.3 ± 0.1 (57)
spk-1(n3418) 0 (56)
spk-l(ok706A) 0 (37)
The number of extra Pn.aap cells were counted as
described in Experimental Procedures. Because spk-
1(n3418) and spk-l(ok706A) cause recessive sterility,
strains containing these alleles were derived from
heterozygous parents; see Experimental Procedures. n,
number of animals.
a All strains are homozygous for nls106, an integrated lin-
11::gfp reporter (REDDIEN et al. 2001).
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Table 2. spk-1(n3418) Suppresses Only the Cell-death Defect of Partial Loss-of-
function Alleles of ced-4
No. extra cells in anterior No. extra Pn.aap
Genotypea pharynx ± SE (n) cells ± SE (n)
ced-4(n3141) 3.0 ± 0.4 (>15)c 4.6 ± 0.1 (50)
ced-4(n3141) spk-1(n3418)b  ND 1.2 - 0.1 (55)
ced-4(n3158) 6.0 ± 0.7 (>15Yc 4.9 ± 0.04 (50)
ced-4(n3158) spk-l(n3418) ND 2.0 ± 0.1 (71)
ced-4(n3040) 11.5 ± 0.4 (>15)c  5.0 ± 0 (52)
ced-4(n3040) spk-1(n3418)b  ND 5.0 - 0 (50)
ced-4(n1162) 11.8 ± 0.2 (>15)c 4.9 ± 0.03 (50)
ced-4(n1162) spk-1(n3418)b ND 4.9 ± 0.04 (58)
The number of extra Pn.aap cells and number of extra cells in anterior pharynx were
counted as described in Experimental Procedures. Because spk-1(n3418) and
spk-1 (ok706A) cause recessive sterility, strains containing these alleles were derived
from heterozygous parents; see Experimental Procedures. n, number of animals.
ND, not determined.
" All strains used to count extra Pn.aap cells are homozygous for nlsl06, an
integrated lin-11::gfp reporter (REDDIEN et al. 2001).
b spk-1(n3418) was cis-marked with lon-1(e185) in each of these strains to facilitate
identification of homozygous animals.
c These data were provided by BRAD HERSH and H. R. H. (unpublished
observations).
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Table 3. spk-J(n3418) Weakly Suppresses the
Survival of Extra Pn.aap Cells of Partial Loss-of-
function Alleles of Some Additional Ced Genes
No. extra Pn.aap
Genotypea cells + SE (n)
ced-3(n242.7) 3.4 ± 0.2 (50)
spk-1(n3418); ced-3(n2427)b  1.2 ± 0.1 (60)
ced-3(n2436) 4.8 ± 0.1 (50)
spk-1(n3418); ced-3(n2436)b 4.0 + 0.1 (52)
ced-9(n3377) 2.3 ± 0.1 (50)
spk-1(n3418) ced-9(n3377)b 1.6 ± 0.1 (67)
egl-1(n3331) 4.7 ± 0.1 (50)
spk-1(n3418); egl-l(n3331)b 4.5 ± 0.1 (48)
egl-1(n4045) 3.8 ± 0.1 (50)
spk-1(n3418); egl-l(n4045)b 3.6 ± 0.1 (60)
The number of extra Pn.aap cells were counted as
described in Experimental Procedures. Because
spk-1(03418) causes recessive sterility, strains
containing this allele were derived from
heterozygous parents; see Experimental
Procedures. n, number of animals.
a All strains are homozygous for nlsl06, an
integrated lin-11::gfp reporter, except those
containing egl-1(n3331), which are homozygous
for the related reporter n1s96 (REDDIEN et al.
b spk-J(n3418) was cis-marked with lon-1(e185)
in each of these strains to facilitate identification
of homozygous animals.
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Chapter Three
Apoptosis of Specific Neuronal Cells in C. elegans Requires
an Enhancer Element of egl-1 that is Bound by a Novel Transcriptional Activator
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H. Robert Horvitz
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SUMMARY
The BH3-only killer gene egl-1 is the most upstream gene that functions in the
execution phase of programmed cell death in C. elegans and is thought to be expressed only
in cells that die. The mechanisms by which egl-1 gene expression is regulated are known for
only a small number of cells that die, including the HSNs, the NSM sister cells, and
P 11.aaap, a neuron located in the posterior ventral nerve cord. From a screen to identify
mutants defective in programmed cell death, we isolated a mutation in egl-1 that lies in an
evolutionarily conserved DNA element four kilobases downstream of the coding sequence.
Both this point mutation and a deletion allele that removes this conserved element prevent
the deaths of the VC-like ventral cord neurons that normally die in hermaphrodites. We
performed a yeast one-hybrid screen to identify proteins capable of binding to this conserved
DNA element. We identified three candidate proteins that could strongly interact with a
reporter construct containing the wild-type enhancer element; two of these three candidates
failed to activate a reporter containing a mutant enhancer element. Analysis of one of these
two candidates, Y38C9A. 1, suggests that it may function to regulate the deaths of the VC-like
neurons in vivo: both dsRNA directed against this gene and two deletion alleles of this gene
can partially prevent the deaths of the VC-like neurons. Y38C9A. 1 encodes a novel protein
with no characterized homologs or obvious DNA binding domains. Thus, we have identified
both a new regulatory site in egl-1 that controls expression in specific neuronal cells and a
novel protein that may bind and activate transcription at this site.
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INTRODUCTION
Programmed cell death, or apoptosis, is the highly regulated process of eliminating
cells that are either unnecessary or deleterious. Apoptosis is essential for the proper
development and health of most animals. The elimination of a wide variety of cells,
including self-reactive immune cells or fibroblasts with DNA damage, prevents the survival
of potentially dangerous cells. The misregulation of apoptosis contributes to numerous
disease processes, ranging from cancer (associated with decreased apoptosis) to forms of
neurodegeneration (associated with increased apoptosis) (FADEEL and ORRENIUS 2005).
During the development of the C. elegans hermaphrodite, 1,090 cells are generated,
131 of which are eliminated by programmed cell death (KIMBLE and HIRSH 1979; SULSTON
and HORVITZ 1977; SULSTON et al. 1983). Many genes have been identified in C. elegans
that function in this process of programmed cell death (LETTRE and HENGARTNER 2006).
Each of these genes can be placed into one of four steps: specification, by which cells
become fated to undergo programmed cell death; execution of the death process; engulfment
of the dying cell by neighboring cells; and the degradation of the dead cell within the
engulfing cell. The conservation of this pathway is highlighted by the fact that related
proteins play similar roles in apoptosis in all animals.
The four C. elegans genes that function in the execution step in all somatic
programmed cell deaths are egl-1 (egl, egg laying defective), ced-9 (ced, cell death
defective), ced-4, and ced-3. egl-1, which encodes a BH3-only (Bcl-2 homology region 3
protein, is thought of as the master regulator of programmed cell death, as it is likely to be
expressed only in cells that die and is the most upstream gene that functions in the death of
all somatic cells (CONRADT and HORVITZ 1998). BH3-only proteins are also key
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pro-apoptotic proteins in mammals (WILLIS and ADAMS 2005). EGL-1 inhibits the
anti-apoptotic function of the Bcl-2 homolog CED-9 (CONRADT and HORVITZ 1998), which
functions to sequester CED-4 (the C. elegans Apaf- 1 ortholog) to mitochondria (CHEN et al.
2000). Binding of EGL-1 to CED-9 liberates CED-4 (CHEN et al. 2000; DEL PESO et al.
2000; DEL PESO et al. 1998; YAN et al. 2004), which can then function to activate the caspase
(cysteine aspartate-specific protease) CED-3 (CHINNAIYAN et al. 1997; SESHAGIRI and
MILLER 1997; WU et al. 1997; YANG et al. 1998). The autoproteolytic activation of CED-3,
the most downstream player in the execution step, provides the critical activity required for
all programmed cell deaths to occur. Elimination of egl-1, ced-4, or ced-3 function, or a
gain-of-function mutation in ced-9, prevents all somatic programmed cell death (CONRADT
and HORVITZ 1998; ELLIS and HORVITZ 1986; HENGARTNER et al. 1992).
The current model is that transcriptional regulation of egl-1 is central to the control of
individual cell deaths; that is, cells in which egl-1 is transcribed die and cells in which egl-1
is not transcribed survive. We understand the transcriptional regulation of egl-1 for only a
small number of the 152 somatic cells that die either in hermaphrodite or male development.
For the two hermaphrodite-specific neurons (HSNs), which control egg laying in the
hermaphrodite and die in the male, the sex-specific repression of egl-1 transcription has been
described. In the HSNs, TRA-1, which is the most downstream gene product in the sex
determination pathway and is specifically active in hermaphrodites, binds to a regulatory
element of egl-1 and prevents its transcription (CONRADT and HORVITZ 1999). In males,
which lack TRA-1 activity, egl-1 transcription in the HSNs is not repressed, and the HSNs
die. In hermaphrodites that contain a mutation disrupting the TRA- binding site that
regulates egl-1 expression in the HSNs, the HSNs inappropriately die (CONRADT and
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HORVITZ 1999). Given that TRA-1 acts as a repressor of egl-1 expression in the HSNs, the
question of what activates egl-1 expression in these cells remains. EOR-1, a putative
transcription factor containing zinc finger domains, and EOR-2, a novel conserved protein,
may function together to promote the death of the HSNs; however, these proteins have not
yet been shown to directly regulate egl-1 transcription (HOEPPNER et al. 2004).
The mechanism of the regulation of egl-1 has also been described for the NSM sister
neurons, which are two pharyngeal neurons that die in wild-type animals. The identification
of gain-of-function mutations in ces-1 helped to define egl-1 regulation in these cells (ELLIS
and HORVITZ 1991). CES-1 is a member of the Snail/Slug family of zinc finger transcription
factors (METZSTEIN and HORVITZ 1999). The egl-1 genomic locus contains a site to which
CES- 1 can bind; a mutation of this site that specifically disrupts CES- 1 binding blocks the
ability of overexpressed CES-1 to protect the NSM sister neurons from death (THELLMANN et
al. 2003). This site overlaps with a binding site for two basic helix-loop-helix (bHLH)
transcription factors, HLH-2 and HLH-3, which promote egl-1 transcription in the NSM
sisters (THELLMANN et al. 2003). The death decision of the NSM sister neurons is thought to
be made by the regulation of the two opposing activities of CES-1 on the one hand and
HLH-2 and HLH-3 on the other.
The mechanism of activation of egl-1 transcription in another dying cell has also been
studied. Analysis of transgenic animals and biochemical assays suggest that the proteins
encoded by the HOX genes ceh-20 and mab-5 directly bind to elements controlling egl-1
expression and activate egl-1 transcription, thereby regulating the death of P 11.aaap, a
posteriorly located cell in the ventral nerve cord (Liu et al. 2006). This work suggests that
HOX genes, which are important developmental genes that regulate body morphology and
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cell fate, can directly regulate cell death by binding to sites within the egl-1 genomic locus
and control egl-1 transcription.
Given the prominent role apoptosis plays in many disease processes, proteins that
bind to and regulate egl-1 expression are good candidates to possess homologs involved in
disease processes. For example, this link with disease has already been established for the
homologs of the proteins that regulate the death of the NSM sister neurons. In addition to
mutations in ces-1, mutations in ces-2 were identified in the genetic screens for mutations
that prevent this death. Gain-of-function mutations in ces-1 and loss-of-function mutations
in ces-2 prevent NSM sister neurons from normally undergoing programmed cell death
(ELLIS and HORVITZ 1991; METZSTEIN et al. 1996). Based on these studies of ces-1 and
ces-2, the mammalian homologs of CES- 1 and CES-2 were shown to function in regulate
apoptosis in hematopoietic and lymphoid cells. CES-2 is similar to the proto-oncogene HLF
(hepatic leukemia factor), a transcriptional repressor (METZSTEIN et al. 1996). The
oncogenic form of this gene is the result of the chromosomal translocation t(17;19), which
fuses the DNA binding domain of HLF to the transactivation domain of E2A (HUNGER et al.
1992; INABA et al. 1992). This chimeric protein binds to and causes overexpression of the
anti-apoptotic CES- 1 homologue SLUG, which can prevent the death of the leukemic pro-B
cells (INUKAI et al. 1999). Recent work suggests that SLUG may directly prevent the
expression of a BH3-only gene, a function highly similar to the function of CES- 1 in
repressing egl-1 expression in the NSM sister neurons of C. elegans (Wu et al. 2005).
In mammalian systems, the transcriptional regulation of genes that encode BH3-only
proteins is one of the major modes by which apoptosis is regulated. Numerous BH3-only
proteins are found in mammalian genomes, including Bim, Bad, Bid, Bik, Bmf, PUMA,
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Noxa, and Hrk (WILLIS and ADAMS 2005). Redundancy has complicated the genetic analysis
of these genes, but some, such as PUMA (p53 upregulated modulator of apoptosis), which is
directly regulated by p53, have well-understood roles as transcriptionally-regulated
regulators of apoptosis. The transcription factor p53 is a critical tumor suppressor gene that
is often mutated in cancers and is an important regulator of apoptosis (HOFSETH et al. 2004).
In its first intron, PUMA has a p53 binding site, which is required for its radiation-induced
transcriptional activation by p53 (Yu et al. 2001). p53 regulation of PUMA appears to be
physiologically relevant, as PUMA-knockout mice closely resemble p53-knockout mice with
respect to apoptosis. Both knockout mice are similarly impaired for apoptosis induced by
y-irradiation in thymocytes, oncogenes in MEFs, and DNA damage in neurons, suggesting
that PUMA is one of the main transcriptional targets of p53 in the induction of apoptosis
(JEFFERS et al. 2003; VILLUNGER et al. 2003).
Given the importance of BH3-only proteins in regulating apoptosis, we sought to
understand the regulation of egl-1 transcription in a subset of cells whose decision to die was
not previously understood. In this work, we identified a conserved enhancer element in egl-1
that controls the death of specific cells in the ventral cord. Using a yeast one-hybrid screen,
we identified the protein Y38C9A. 1, which binds to this element and may directly regulate
the transcription of egl-1 in these cells in vivo. Deletions of either the egl-1 non-coding
element or Y38C9A. I each promote survival in the same cells. Y38C9A. I1 may encode a
novel DNA-binding protein, as it has no characterized homologs or recognizable domains
from any previously identified transcription factors.
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RESULTS
Identification of a Mutation in an Evolutionarily Conserved DNA Element in egl-1
We performed a screen seeking mutants defective in programmed cell death in C.
elegans by screening for enhancers of the cell-death defect of animals containing the mutation
n2427 (HENGARTNER and HORVITZ 1994), a weak loss-of-function allele of the caspase gene
ced-3. To assess the amount of cell death, we used a modified lin-11::gfp reporter that is
expressed in neurons of the Pn.aap lineage in the ventral cord (REDDIEN and HORVITZ 2004).
In the C. elegans ventral nerve cord of the hermaphrodite, twelve cells are generated in the
lineal position Pn.aap (the posterior daughter of the anterior daughter of the anterior daughter
of one of twelve P blast cells); six of those twelve (the two anterior-most, Pl.aap and P2.aap,
and the four posterior-most, P9-P12.aap) die by programmed cell death (Figure lA)
(SULSTON and HORVITZ 1977). The six Pn.aap cells that survive differentiate into class VC
motor neurons, some of which innervate the vulval muscles of the adult hermaphrodite. The
modified lin-ll::gfp reporter nls106 expresses in Pn.aap cells, including Pn.aap cells that are
normally fated to die but whose deaths have been prevented by mutations blocking
programmed cell death (REDDIEN et al. 2001). These cells that usually die but whose death is
prevented will be called VC-like neurons in this chapter, because they closely resemble the
VC motor neurons that survive in wild-type animals (WHITE et al. 1991). Five of these
VC-like neurons can be reliably scored by assaying expression of lin-ll::gfp (REDDIEN et al.
2001). This reporter is extremely useful in studying programmed cell death, because it
provides a measure of programmed cell death that is both quantifiable at the single-animal
level and easily scored using a dissecting microscope equipped with fluorescence optics. In
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our screen, we isolated lin-ll::gfp animals possessing an increased number of GFP-positive
cells, reflecting a possible defect in programmed cell death.
One mutation we identified in our screen was designated n4045. This mutation
promoted survival of GFP-positive VC-like neurons that normally undergo programmed cell
death (Table 1). This effect on VC-like neuron survival was not dependent on a defect in
ced-3 killing activity, as n4045 strongly protected these cells when it had been separated
from the ced-3(n2427) mutation used in the screen (Figure 1, Table 1). We mapped n4045 to
an interval containing the known regulator of programmed cell death egl-1. n4045 failed to
complement the Ced phenotype of a loss-of-function allele of egl-l(nl084 n3082) in the
VC-like neurons (data not shown). A single mutation was found in the strain containing this
allele, located approximately four kilobases downstream of the coding region of egl-1
(Figure 2). This mutation lies in a small region that is highly conserved in sequence and
location in the genomes of the two Caenorhabditis species with sequenced genomes, C.
briggsae and C. remanei (Figure 2). These three species are distantly related nematodes in
which only coding sequences and important regulatory regions are thought to be conserved.
We named this DNA element in egl-1 the VCK (VC-like neuron killing) element.
Isolation of Additional egl-1 Alleles Mutated in the VCK Element
To identify additional alleles of egl-1 that might help better define the VCK element,
we performed an egl-1 non-complementation screen using the lin-11::gfp reporter. We
mated mutagenized males with egl-(l) hermaphrodites and screened for animals with
undead VC-like neurons. In a screen of approximately 13,000 haploid genomes, the single
egl-1 allele n4629 was isolated (Table 1). n4629 caused the identical base change identified
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in egl-l(n4045) (Figure 2). This independent isolation of the identical mutation strongly
suggested that this sequence alteration was responsible for the observed phenotype of
survival of the VC-like neurons.
At this point we could not distinguish between two models of how this point mutation
was behaving: the mutation might disrupt the binding of a transcriptional activator or it might
increase binding of a transcriptional repressor, perhaps by creating a regulatory site not
normally found in this location. To distinguish between these two models we sought a
deletion of the VCK element. A very small deletion of 309 base pairs was isolated from a
library of mutagenized C. elegans, n4908A (Figure 2). This deletion was centered on the
n4045 mutation such that approximately 150 base pairs were eliminated on both sides of the
point mutation. n4908A was able to phenocopy the point mutations n4045 and n4629,
establishing this site as a binding site for a transcriptional activator. Unlike the two point
mutations, the deletion allele completely eliminated the deaths of all VC-like neurons,
suggesting that the point mutations do not completely eliminate the binding of the
transcriptional activator (Table 1).
The VCK Element Specifically Controls Cell Death of the VC-like Neurons
The mutations in the VCK element of egl-1 that we isolated strongly prevented the
deaths of the VC-like neurons that normally die in wild-type hermaphrodites. It remained to
be determined whether this effect was specific to these cells or the consequence of a more
general loss of egl-1 function, affecting the deaths of other cells that normally die in C.
elegans. Another anatomical region in which cell death is routinely assayed is the anterior
pharynx; the cells of this region can readily be counted using Nomarski differential-
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interference contrast microscopy (HENGARTNER et al. 1992). Sixteen cells of the anterior
pharynx, arising from multiple lineages, normally undergo programmed cell death, and the
number of these cells that inappropriately survive provides a quantitative assay of possible
defects in programmed cell death. In the anterior pharynx, no additional cells were observed
in strains containing the egl-I mutation n4045 or the VCK deletion allele n4908A (Table 2).
Additionally, when these alleles were assayed in the presence of a weak ced-3 allele, n2427,
which provides a sensitized background in which very weak cell-death defects can be
detected (REDDIEN et al. 2001), no enhancement of the weak survival caused by
ced-3(n2427) was observed (Table 2). These findings suggest that the mutations in the VCK
element specifically prevent the death of the VC-like neurons. Thus, the VCK enhancer
element appears to promote tissue-specific activation of egl-1 transcription.
A Yeast One-Hybrid Screen Identified Proteins that Bind the VCK element
To identify proteins that bind to the VCK element, we undertook a yeast one-hybrid
screen. The yeast-one-hybrid system is conceptually similar to the yeast two-hybrid system
that is used for the detection of protein-protein interactions (CHIEN et al. 1991). In the yeast
one-hybrid system, a single hybrid protein containing a C. elegans cDNA fused to a strong,
heterologous activation domain is tested for reporter gene activation, which occurs when the
hybrid protein interacts with the DNA bait containing the DNA element of interest (LI and
HERSKOWITZ 1993). The reporter construct used in these one-hybrid screens contained eight
copies of a 31 base-pair element centered on the point mutation found in egl-1(n4045) and
egl-1(n4629) (Figure 3A). Versions of this reporter were generated containing the wild-type
sequence and the n4045 mutant version, both for screening purposes and to determine
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whether candidate interactors specifically activate the wild-type reporter but not the mutant
reporter. Two types of screens were conducted in parallel. In the first, we tested the ability
of approximately two-thirds of the 1,000 predicted transcription factors (DEPLANCKE et al.
2004) in the C. elegans genome to bind to the VCK element. In the second, we screened a
library of most C. elegans cDNAs fused to an activation domain (WALHOUT et al. 2000) for
candidates that bind to the VCK element.
None of the predicted C. elegans transcription factors that we tested activated the
wild-type or mutant reporters. They were tested on yeast strains containing the egl-1
reporters by either individually mating yeast strains containing each of the transcription
factor fusions or by transformation with a library containing only these transcription factor
fusions. Three candidates that successfully retested were identified from the cDNA library
screen. Y38C9A. I1 was isolated three times from the cDNA library screen with the wild-type
reporter. B0238. 11 was isolated once from the cDNA library screen with the wild-type
reporter. The last candidate was defined by a cDNA containing Y38F1 1.3 and parts of two
adjacent predicted genes (Y43F1 1.5 and Y38F1 1.2); this cDNA was recovered three times,
once when screening using the wild-type reporter and twice when screening using the mutant
reporter.
When each of these isolates was retested against both the mutant and wild-type
reporters, both Y38C9A. I1 and B0238. 11 selectively activated the wild-type reporter, whereas
Y43F11.3 activated the mutant and wild-type reporters equally (Figure 3B). The selective
activation of the wild-type but not the n4045 mutant reporters by both Y38C9A. 1 and
B0238. 11 was of particular interest, because such a profile might represent genes whose
binding to the enhancer element is prevented by the point mutation. Thus, these two genes
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are candidates for functioning in vivo to regulate egl-1 transcription in the VC-like neurons
that normally undergo programmed cell death. Of the three predicted proteins we found that
could interact with the egl-1 enhancer element in the yeast one-hybrid system, only one,
B0238.11, is predicted to contain a recognizable DNA-binding domain, a high mobility
group (HMG) box domain (BIANCHI 1995).
Inactivation of Y38C9A.1 Promotes the Survival of VC-like Neurons
To determine whether the candidates isolated in the yeast one-hybrid screen function
to regulate the death of the VC-like neurons, we screened a library of mutagenized C.
elegans and isolated animals carrying deletions in each of the three candidate interactors
(Figure 3C). These deletions were each tested using the modified lin-11::gfp reporter nls106
to determine whether they promoted survival of the VC-like neurons that normally undergo
programmed cell death. The deletion allele n4909A eliminates Y43F 1.3, the only predicted
gene wholly contained in the yeast one-hybrid screen isolate that also contains part of
Y43F11.5 and Y43F11.2. Animals containing this deletion appeared superficially wild-type
and did not promote survival of VC-like neurons. n4904A, which deletes B0238.11, causes
early larval arrest, consistent with the phenotype we observed by injection of dsRNA directed
against this gene (data not shown). None of the small number of animals that developed far
enough to express gfp from the lin-ll::gfp reporter had surviving VC-like neurons.
Two deletion alleles of Y38C9A. 1, n4799A and n4917A, as well as injection of
dsRNA directed against Y38C9A.1, caused several abnormalities. Most significantly, the
deletions caused survival of VC-like neurons that normally die. In Figure 4A, a confocal
image is shown of a representative animal carrying a deletion in Y38C9A. 1, and harboring
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surviving VC-like neurons. This finding is consistent with a role for Y38C9A. I in the control
of the death of the VC-like neurons. Additionally, in combination with the lin-ll::gfp
reporter nIs106, the Y38C9A.1 deletion alleles appear to cause an alteration in sex
determination, since animals were observed that contained sexual characteristics of both
hermaphrodites and males.
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DISCUSSION
Transcriptional control of egl-1, a BH3-only protein-encoding gene, is the primary
mechanism of regulating somatic programmed cell death in C. elegans (CONRADT and
HORVITZ 1998). Similarly, transcriptional activation of the pro-apoptotic BH3-only proteins
is fundamental to the regulation of apoptosis in mammals (WILLIS and ADAMS 2005). Thus
an understanding of how egl-1 is regulated in cell death is critically important. This work
has established a mechanism of transcriptional control of egl-1 in specific cells, the VC-like
neurons in the ventral nerve cord, in which the mechanism of egl-1 activation was previously
uncharacterized. By means of a genetic screen, we identified a non-coding regulatory site of
egl-1 required for the death of the VC-like neurons. Genetic analysis suggests that mutations
in this VCK element can perturb the binding of a transcriptional activator. We identified
three proteins capable of binding to the VCK element in a yeast one-hybrid assay and found
that one of these proteins may regulate egl-1 transcription in vivo. This protein product of
the Y38C9A. I gene has no known DNA-binding domains and thus may contain a previously
unidentified DNA-binding domain.
Deletion of Y38C9A. I caused abnormalities not observed in strains carrying
mutations in the VCK element, demonstrating that Y38C9A. 1 affects processes in addition to
egl-1 activation in the VC-like neurons. The observed survival of the VC-like neurons might
be a result of perturbation of sexual identity rather than a defect in the specification of death
of the VC-like neurons, as some animals carrying a deletion in Y38C9A. 1 display sexual
characteristics of both males and hermaphrodites. Alternatively, Y38C9A. I might control
VC-like neuron survival and also function in other independent processes in C. elegans,
possibly explaining why this gene has not been isolated in the numerous screens performed
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with this reporter. Significantly, deletion of Y38C9A.1 did not promote survival of the
VC-like neurons as strongly as did mutations in the non-coding egl-1 regulatory element.
This result suggests that Y38C9A. 1 is unlikely to be the only activator that binds to this site.
It remains to be seen whether two or more of the three candidates isolated in the yeast
one-hybrid screen might act redundantly to control VC-like neuron cell death.
Consistent with our studies of Y38C9A. 1, Previously identified egl-1 regulators seem
to be involved in multiple processes and are not exclusively devoted to regulating egl-1
transcription to control cell death. TRA-1, which represses egl-J transcription in the HSNs,
is a master regulator of sex determination (MEYER 2000). Mutations in eor-1 and eor-2, two
genes that promote HSN cell death, both cause a range of abnormalities, including
incompletely penetrant lethality (HOEPPNER et al. 2004). hlh-2, which activates transcription
of egl-1 in the NSM sister cells, is essential (KRAUSE et al. 1997), as is ceh-20, which
activates egl-1 in Pl l.aaap, a cell near the tail (LIU et al. 2006). The partner with which
CEH-20 dimerizes to control egl-] expression in the P11 .aaap cell, MAB-5, is not essential,
but animals lacking mab-5 function show cell lineage defects in the tail region, including the
cells whose survival mab-5 appears to directly control (KENYON 1986). CES-2 is a regulator
of excretory canal cell morphogenesis (WANG et al. 2006) in addition to controlling egl-1
expression in the NSM sister cells (METZSTEIN et al. 1996; THELLMANN et al. 2003). Our
work demonstrates that deletions of Y38C9A. 1, in addition to promoting survival of the
VC-like neurons, cause abnormalities in sex determination that lead to animals displaying
characteristics of both males and hermaphrodites.
To date, only two transcriptional factors seem to regulate egl-1 specifically and not
affect additional processes: HLH-3, which has a very weak influence on cell death and
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appears to act primarily as a cofactor for regulation of egl-1 expression by the essential gene
hlh-2 (THELLMANN et al. 2003); and CES-1, which acts to repress egl-1 expression in the
NSM sisters (THELLMANN et al. 2003). It remains highly possible that HLH-3 and CES-1
possess additional functions, as yet unknown, beyond their cell-specific roles in the control
of programmed cell death.
Although egl-I transcription has been suspected of being the main control mechanism
of programmed cell death in C. elegans, a limited number of genes that control its expression
have been identified. The well understood regulation of egl-1 in the HSNs was established in
a way that is similar to this work, by identifying non-coding mutations in egl-1 that alter the
survival decision of a specific cell (CONRADT and HORVITZ 1999). Mutational analysis of the
egl-1 locus using extrachromosomal arrays in transgenic animals was important for
establishing the roles of hlh-2, hlh-3, ceh-20, and mab-5 in the regulation of egl-
transcription. It is very likely that the transcription factors that regulate egl-1 expression
function in many processes in addition to programmed cell death, such that they cannot be
identified in genetic screens. This has certainly been the case for most genes that regulate
egl-1 expression studied to date. The genetic approaches used in this manuscript of
identifying non-coding regulatory regions in egl-1, and then using these regulatory regions to
identify proteins that bind to them, may therefore be the most useful method of identifying
additional factors that control the survival decisions of specific cells by regulating egl-1
expression.
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FUTURE DIRECTIONS
The current data suggest that genes that regulate egl-1 expression in a cell-specific
fashion might not function solely to regulate egl-1 expression; rather, loss-of-function
mutations in these genes might well cause additional phenotypic defects, making such
mutations difficult to isolate in screens. Our work and other related work suggest that an
alternative genetic approach to identifying genes that regulate egl-1 expression is to identify
functional regulatory elements of egl-1 and then identify proteins that bind to these sites by
methods such as one-hybrid screens. These regulatory elements can be identified by
recovering animals from a genetic screen, most efficiently in an egl-1 non-complementation
screen as demonstrated in this work. Alternatively, one can test mutant strains deleted for
genomic regions near to the egl-l coding region, an approach this work also validates. In the
case of the targeted deletions, it may be possible by means of rescue experiments or by a
return to egl-1 non-complementation screens to identify within a larger deletion the specific
regulatory element responsible for cell-specific control of egl-1 expression. Further
understanding of the regulation of egl-1 expression and the expression of mammalian
BH3-only genes is clearly critical to our understanding of programmed cell death, so taking a
non-standard approach to isolating egl-1 transcription factors seems warranted. Approaches
such as are described above and those we have used in this work may serve to identify new
regulatory regions and the factors that act upon them.
In the yeast one-hybrid screen, I identified two additional genes that remain to be
characterized. Given their strong interaction with egl-1 in the yeast one-hybrid assay, it is
possible that these genes regulate egl-1 expression in cells other than the VC-like neurons.
Worms carrying deletions in each of these genes should be examined for other cell-death
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defects. Recent data suggest that the egl-1 deletion allele n4908 might also promote survival
of the male-specific CEM neurons, which normally die in hermaphrodites (in contrast to the
point mutation we originally isolated, which does not protect these cells) (H. SCHWARTZ,
personal communication). Perhaps one of the genes identified in the yeast one-hybrid screen
regulates the death of these cells, or alternatively the 309 bp deletion might eliminate another
element that specifically contributes to the regulation of those deaths.
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EXPERIMENTAL PROCEDURES
Strains and Genetics
Strains were cultured as described by BRENNER (1974) and grown at 200 C on NGM
agar using E. coli OP50 as a food source. The Bristol strain N2 was the wild-type strain.
The mutations and balancer chromosomes used in the study are as follows and are previously
described (RIDDLE et al. 1997) unless otherwise indicated:
LGI, dpy-5(e61), nIs133 [pkd-2::gfp; lin-15AB(+)] (JAGER et al. 2004)
LGII, rol-6(e187), Y43F11A.3(n4909A) (this study), rrf-3(pk1426)
LGIII, unc-32(e189)
LGIV, ced-3(n717), ced-3(n2427) (HENGARTNER and HORVITZ 1994), unc-30(e191)
LGV, dpy-11(e224), rol-4(sc8), unc-42(e270), unc-76(e911), egl-1(n1084 n3082)
(CONRADT and HORVITZ 1998), egl-1(n4045, n4629, n4908A) (this study),
Y38C9A. I(n4799A) (this study), Y38C9A. J(n491 7A) (this study), B0238. 11(n4904A) (this
study)
LGX, lon-2(e678), nlsl 106 [lin-11::gfp; lin-15AB(+)] (REDDIEN et al. 2001).
The translocation nT1 IV;V with the dominant marker qls51 [myo-2::gfp] (SIEGFRIED
et al. 2004) was used as a balancer for B0238. 11 (n4908A).
Identification and Mapping of egl-l(n4045)
We mutagenized L4 ced-3(n2427); nIsl06 hermaphrodites with ethyl
methanesulfonate (EMS) as described by BRENNER (1974). After letting the animals recover,
single Po animals were transferred to 9-cm plates. After 6-8 days F2 animals on these plates
were screened for animals with five surviving GFP-positive VC-like neurons. n4045 was
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mapped to linkage group V using the markers dpy-5 I, rol-6 II, unc-32 III, unc-30 IV, dpy-11
V, and lon-2 X (BRENNER 1974). Further mapping placed n4045 approximately 13/20 of the
distance from rol-4 to unc- 76 on LGV, a position consistent with those of two genes known
to cause survival of VC-like neurons in hermaphrodites, egl-1 and sel-10. Further
investigation demonstrated that n4045 did not cause defects consistent with a mutation in
sel-10 (H. SCHWARTZ, personal communication).
egl-1 Non-complementation Screen
We mutagenized L4 nls133; nls106 males with EMS as described by BRENNER
(1974) and mated them with nls133; rol-4(sc8) egl-1(n1084n3082) unc-76(e911); nls106
hermaphrodites. After 3-4 days, F, non-Rol non-Unc cross progeny were screened to
identify animals with surviving GFP-positive VC-like neurons.
Quantitation of Cell Death in the VC-like neurons and the Anterior Pharynx
VC-like neurons expressing GFP were visualized using a dissecting microscope
equipped with fluorescence optics (M2BIO, Kramer Scientific, Valley Cottage, NY).
Animals late in the fourth larval stage were picked using a standard dissecting microscope
and transferred to the fluorescence-equipped dissecting microscope for counting of their
surviving VC-like neurons.
Nomarski differential-interference contrast microscopy was used to count the number
of extra cells in the anterior region of the pharynx as previously described (HENGARTNER et
al. 1992).
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Determination of Mutant Allele Sequences
We used PCR-amplified regions of genomic DNA to determine mutant sequences.
For egl-1(n4045), we determined the sequence of approximately 13 kb surrounding the gene.
For egl-1(n4629), we determined the sequence of the coding region and the interval
containing the egl-I(n4045) mutation. For egl-1(n4908A), we determined the sequence of
the interval containing the deletion. Sequences were determined using an ABI Prism 3100
Genetic Analyzer.
Generation of Yeast One-Hybrid Reporter Constructs and Strains
To generate a DNA bait construct containing eight copies of the 31 base-pair DNA
element centered on the n4045 mutation, four pairs of complementary oligonucleotides, each
containing two copies of the element, were annealed and ligated into pUC19. M13 primers
flanked by Gateway-compatible cloning sites were used to PCR-amplify the 8X DNA
element, after which the resulting PCR amplicon was cloned via a Gateway BP reaction into
the entry vector pDONR-P4-P1R, as described (DEPLANCKE et al. 2004). One
sequence-verified entry clone was then used for LR cloning into the destination vectors and
integrated into the genome of YM4271 yeast, as described (DEPLANCKE et al. 2004). Bait
strains were verified by PCR of yeast genomic DNA using vector-specific primers, after
which PCR amplicons were sequenced. Self-activation of promoter bait strains was tested as
described (DEPLANCKE et al. 2004).
Yeast One-Hybrid Screens
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Mating experiments using strains of opposite mating types, one containing the
promoter bait and the other containing the AD-TFs (Activation Domain-Transcription
Factors) (B. DEPLANCKE and A. J. M. WALHOUT, unpublished data) were performed as
described (WALHOUT and VIDAL 2001).
Promoter bait strains were transformed with the AD-wrmcDNA (C. elegans cDNAs)
and AD-TF libraries as described (DEPLANCKE et al. 2004), and plated onto Sc-His, -Ura,
-Trp media containing 40mM 3AT. 9.4 x 106 and 3.8 x 105 colonies were screened per strain
for the AD-wrmcDNA and AD-TF libraries, respectively, for the wild-type reporter. 2.5 x
106 and 3.4 x 105 colonies were screened per strain for the AD-wrmcDNA and AD-TF
libraries, respectively, for the n4045 mutant reporter. Potential positives were picked and
retested as described (DEPLANCKE et al. 2004). To sequence ORFs encoding potential
interactors, yeast colony PCR was performed as described (WALHOUT and VIDAL 2001).
Gap-repair-based phenotypic retesting was performed as described (WALHOUT and VIDAL
2001).
RNA Interference of Candidates Isolated in the Yeast One-Hybrid Screen
Vector-specific primers flanked by T7 binding sites were used to PCR-amplify the
one-hybrid isolates that retested. To generate double-stranded RNA, a MEGAscript® T7 Kit
(Ambion, Austin, TX) was used according to the manufacturer's specifications. dsRNA for
each isolate was injected into the gonad of rrf-3(pk1426); nIsl06 worms. The F1 progeny
were scored for extra GFP-positive VC-like neurons and other abnormalities.
Isolation of Deletion Alleles
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Genomic DNA pools from the progeny of EMS-mutagenized animals were screened
to identify deletions using PCR as previously described (CEOL and HORVITZ 2001). Deletion
mutant animals were isolated from frozen stocks and backcrossed to the wild type.
egl-](n4908A) removes nucleotides 1819 to 2127 of plasmid VF23B12L.
Y38C9A. (n4799A) removes nucleotides 530 to 2807 of YAC Y38C9A. Y38C9A.I(n4917A)
removes nucleotides 8199 to 11139 of YAC Y38C9A. B0238.11(n4904A) removes
nucleotides 28722 to 30199 of cosmid B0238. Y43FllA.3(n4909A) removes nucleotides
5846 to 7310 of YAC Y43F11A.
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FIGURE LEGENDS
Figure 1: egl-l(n4045) Promotes Survival of VC-like Neurons
(A) In the ventral cord, the twelve P cells P1-P12 each divide post embryonically to generate
a Pn.a (n is 1-12) neuroblast and a Pn.p hypodermal cell. P3-8 give rise to the six Pn.aap
cells that survive and differentiate into the VC motor neurons, whereas P1, 2, 9 - 12 give rise
to Pn.aap cells that undergo programmed cell death shortly after they are generated, in the
late Li/early L2 larval stage. The modified lin-1l::gfp reporter nlsl06 reliably expresses in
any of the eleven Pn.aap cells generated by P2 - P12 if they survive through the fourth larval
stage.
(B) Confocal images of nlsl06 expression patterns. In wild-type animals containing the
modified lin-.ll::gfp reporter nlsl06, four of the six VC neurons generated by the P3-5, and
P8 lineages, can be easily observed by fluorescence microscopy, whereas the fluorescence
from VC neurons generated by the P6 and P7 lineages is obscured by GFP fluorescence in
vulval tissue. In egl-l(n4045) animals, P2 - P12.aap cells usually survive and express gfp.
Figure 2: n4045 and n4629 Are Identical Mutations in the VCK Element of egl-I
A schematic representation of the egl-1 locus, showing the locations and sequences of the
egl-1(n4045), egl-l(n4629), and egl-1(n4908A) alleles and their evolutionary conservation.
In the alignment of the conserved DNA element 3' of egl- I in C. elegans, C. briggsae, and C.
remanei, identical nucleotides are shaded. The DNA element in C. elegans has the opposite
orientation of that found in C. briggsae and C. remanei.
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Figure 3: Three Proteins Bind to the VCK Element of egl-1 in A Yeast One-Hybrid
Assay
(A) Schematic of the HIS3 reporters used in the yeast one-hybrid assays.
(B) Isolates from the yeast one-hybrid screen were tested for their ability to allow HIS3-
yeast strains to grow in the absence of His by assaying for their abilities to activate the HIS3
reporters containing eight copies of either the wild-type (+) or mutant (n4045) VCK element.
Cells were plated on Sc -His, -Ura media supplemented with 20 mM 3AT.
(C) Schematic representation of genes that encode the proteins isolated in the one-hybrid
screen, showing the location of the deletion alleles (n4799A, n4917A, n4904A, and n4909A)
isolated for each gene.
Figure 4: Y38C9A.1 Functions to Promote the Deaths of VC-like Neurons
(A) Confocal image of Y38C9A.1 (n4799A); nIs106 animals, which display fluorescence in
VC-like neurons that failed to die.
(B) Model for the death of VC-like neurons. In VC-like neurons that die in wild-type
animals, Y38C9A. 1 binds to the VCK element in egl-1 defined by n4045 and promotes
transcription of egl-]. In either the absence of a functional VCK element or in the absence of
Y38C9A.1, egl-1 transcription is not promoted and the cells inappropriately survive.
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Table 1. Mutations in the VCK Element in egl-1
Promote Survival of VC-like Neurons
No. of VC-like
Genotype neurons ± SE (n)
Wild type
ced-3(n2427)
ced-3(n242 7); egl-1 (n4045)
egl-1(n4045)
egl-](n4629)
egl-1 (n4908A)
egl- I(null)^
ced-3(n717)
0 ± 0 (109)
2.4 ± 0.2 (50)
5.0 + 0.1 (102)
4.5 + 0.1 (50)
4.4 + 0.1 (50)
5.0 + 0 (50)
5.0 + 0 (25)
5.0 + 0.1 (25)
VC-like neurons counted as described in
Experimental Procedures. n, number of animals.
SE, standard error.
All strains were homozygous for nIs106, the
integrated lin-ll::gfp reporter. Genotypes are
otherwise indicated.
A egl-1(n1084 n3082)
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Table 2. Mutations in the VCK Element in egl-1 Do Not
Promote Survival of Extra Cells in the Anterior Pharynx
No. of extra cells in anterior
Genotype pharynx ± SE (n)
Wild type 0 + 0 (20)
egl-1(n4045) 0 ± 0 (10)
egl-1(n4908A) 0.1 ± 0.1 (10)
ced-3(n2427) 1.3 ± 0.3 (10)
ced-3(n2427); egl-1(n4045) 1.3 ± 0.3 (10)
ced-3(n2427); egl-1(n4908A) 1.2 ± 0.3 (10)
egl-l (null)A  11.1 ± 0.1 (113)
ced-3 (n 717) 12.0 ± 0.3 (20)
Number of extra cells counted as described in
Experimental Procedures. n, number of animals. SE,
standard error.
A egl-l(n1084 n3082); these data were taken from
CONRADT and HORVITZ (1998).
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Chapter Four
Mutations in Two Novel Genes, lin-24 and lin-33, Cause Cytotoxic Cell Death
in C. elegans that Requires Apoptotic Corpse Removal Genes
Brendan D. Galvin, Saechin Kim, and H. Robert Horvitz
Saechin Kim initiated preliminary characterization of lin-24 and lin-33 and cloned lin-24.
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SUMMARY
In C. elegans, two types of cell death have been studied extensively: programmed cell
death and necrosis. In this work we characterize a novel type of cell death that occurs
inappropriately in animals containing mutations in one of two novel genes, lin-24 and lin-33.
Gain-of-function mutations in the genes lin-24 and lin-33 can cause either the inappropriate
deaths of the Pn.p cells or prevent these cells from adopting their proper fates. Since some of
the Pn.p cells are vulval precursor cells, lin-24 and lin-33 gain-of-function mutations result in
a vulvaless hermaphrodite. We showed that the corpses resulting from the Pn.p cells that die
in lin-24 and lin-33 mutant animals are morphologically and ultrastructurally distinct from
the corpses that characterize programmed cell deaths and cells that die by necrosis in C.
elegans. We have molecularly identified both genes and found that lin-24 encodes a protein
containing a domain similar to one found in numerous bacterial toxins and that lin-33
encodes a novel protein. We showed that the cytotoxicity caused by mutation of either gene
requires the function of the other, demonstrating that these two genes work together in this
process. The Pn.p cell cytotoxicity of lin-24 and lin-33 mutations also requires a subset of
the genes necessary for the engulfment of cell corpses during programmed cell death. Thus,
we conclude that the engulfment genes from the programmed cell death pathway also
function in the process of cell killing initiated by lin-24 and lin-33 mutations, even though
these deaths are distinct from programmed cell deaths and do not require the execution genes
from this pathway.
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INTRODUCTION
During the development of the C. elegans hermaphrodite, 131 of the 1030 somatic
cells that are generated are eliminated by the process of programmed cell death or apoptosis
(KIMBLE and HIRSH 1979; SULSTON and HORVITZ 1977; SULSTON et al. 1983). The
identification of the genes that function in this pathway provided valuable insights into this
conserved process. For example, molecular identification of the caspase gene ced-3 defined
the first biochemical mechanism of apoptosis (YUAN et al. 1993). Caspases are cysteine
aspartate-specific proteases that act in apoptosis in all animals (DEGTEREV et al. 2003).
Similarly, studies of C. elegans ced-9 and human Bcl-2 revealed that the misregulation of
apoptosis can cause human disease, in this case, cancer (HENGARTNER and HORVITZ 1994;
VAUX et al. 1992). More than 20 genes have been identified in C. elegans that function in
programmed cell death, and many have homologs that function in mammalian apoptosis
(METZSTEIN et al. 1998).
Apoptosis is not the sole mechanism of cell death; cells can also die by necrosis and
by autophagy. In autophagy, cells consume themselves from within, for example, under
situations of nutritional deprivation (EDINGER and THOMPSON 2004). There are currently no
examples of autophagic deaths in C. elegans. Necrosis is the cellular death process defined
largely by ultrastructure, which includes the swelling of organelles and loss of plasma
membrane integrity. Necrosis can be caused by injury or physiological insult and contributes
significantly to human diseases, such as the immediate tissue damage that occurs after a heart
attack due to lack of oxygen (ZONG and THOMPSON 2006). Some cell deaths that occur in C.
elegans ultrastructurally resemble necrotic cell death. The best understood necrotic deaths in
C elegans are the deaths caused by gain-of-function mutations in the gene encoding the
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mechanosensory sodium channel subunit MEC-4 (DRISCOLL and CHALFIE 1991). Mutations
in several other genes, such as deg-1 (encoding a related channel subunit) (CHALFIE and
WOLINSKY 1990), deg-3 (encoding an acetylcholine gated ion channel) (TREININ and
CHALFIE 1995), and activated transgenic Gas (BERGER et al. 1998; KORSWAGEN et al. 1997),
probably act by a similar mechanism. The gain-of-function mutations in mec-4 cause the
hyperactivation of DEC/ENaC channels and cause the deaths of the six touch-receptor
neurons in which this subunit is expressed (LAI et al. 1996). These deaths seem to require
release of calcium from the endoplasmic reticulum (Xu et al. 2001) and the activation of the
calcium-activated calpain proteases and specific cathepsin aspartyl proteases (SYNTICHAKI et
al. 2002). This death process is similar to that proposed for channel-mediated toxicity in
mammals (DRISCOLL and GERSTBREIN 2003).
We have observed and characterized a third type of cell death in C. elegans that is
distinct from necrotic cell death and programmed cell death, which we refer to as
cytotoxicity. This novel type of cell death occurs in C. elegans containing mutations in
either one of two genes, lin-24 or lin-33. The genes lin-24 and lin-33 were identified in
screens for mutants abnormal in vulval cell lineages (FERGUSON and HORVITZ 1985). These
mutations cause a vulvaless phenotype. Additional alleles of each gene that cause the same
phenotype were isolated in a screen for egg-laying defective mutants (TRENT et al. 1983) and
in a screen for suppressors of the multivulva phenotype (S. G. CLARK & H. R. HORVITZ,
unpublished results). In this work, we show that the vulvaless phenotype is due to a novel
type of cell death that inappropriately occurs in the vulval precursor cells in lin-24 and lin-33
mutant animals.
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RESULTS
Mutations in lin-24 and lin-33 Cause Both Inappropriate Cell Deaths and Aberrant Cell
Fates of Pn.p cells
C. elegans strains with mutations in the genes lin-24 and lin-33 had been isolated
previously as having a vulvaless phenotype or being unable to lay eggs (FERGUSON and
HORVITZ 1985; TRENT et al. 1983). To determine the cause of the vulvaless phenotype, we
directly observed the Pn.p cells in lin-24 and lin-33 mutants using Nomarski differential
interference contrast microscopy. The Pn.p cells were examined because these cells
normally give rise to the vulva, and the mutant animals are vulvaless. We confirmed that, in
lin-24 and lin-33 mutants, these cells frequently look abnormal and either die inappropriately
or survive but fail to adopt their proper cell fates, as previously reported (FERGUSON and
HORVITZ 1985; FERGUSON et al. 1987). We observed that late in the first larval stage (L1) or
early in the second larval stage (L2) in lin-24 or lin-33 mutant hermaphrodites, the nuclei of
many of the Pn.p cells increase in refractility and form non-circular refractile bodies that can
persist for minutes to hours (Figure 1). Once the refractility begins to decrease, one of three
outcomes is observed: the cell dies, the cell survives but the nucleus is abnormally small, or
the cell survives and the nucleus looks normal. The refractile bodies are distinct from the
circular and more highly refractile corpses seen in programmed cell death (SULSTON and
HORVITZ 1977). The refractile bodies are also distinct from necrotic corpses, which swell to
several times their original diameter (CHALFIE and SULSTON 1981; CHALFIE and WOLINSKY
1990). We tracked 176 Pn.p cells from the mid-L1 larval stage to the early L2 larval stage in
16 lin-24(n2050) animals and observed that 31 died inappropriately (18%), two survived but
had small nuclei, and 143 returned to looking normal. For lin-33(n2003), 38 of the 99 cells
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we tracked died inappropriately (38%), six had small nuclei, and the remaining 55 returned to
looking normal.
The surviving Pn.p cells failed to adopt their correct cell fates in lin-24 and lin-33
mutants. Three of the 12 cells, P(5-7).p, normally undergo three rounds of division to
generate the cells that form the vulva (SULSTON and HORVITZ 1977). Three neighboring cells
P(3, 4, 8).p, although competent to make vulval cells, normally divide once to generate two
descendants that fuse with the hypodermis (SULSTON and HORVITZ 1977; SULSTON and
WHITE 1980). We examined the fates of P(3-8).p in lin-24 and lin-33 mutant animals and
observed that these cells almost never divided. In lin-24(n2050) animals, of the 56 cells we
tracked, all but two never divided. Instead these cells probably went on to fuse with the
hypodermal syncytium, a fate normally assumed by P(1,2).p, P(9-12).p. Therefore, the
abnormal death of 20-30% of the Pn.p cells, combined with the adoption of abnormal cell
fates by the remaining cells, causes the vulvaless phenotype observed in lin-24 and lin-33
mutant animals.
The Abnormal Cells in lin-24 and lin-33 Mutant Animals Are Distinct from Cells that
Undergo Necrotic or Programmed Cell Deaths
We examined the ultrastructure of the abnormal Pn.p cells in lin-24 and lin-33
mutants by electron microscopy. Hallmarks of programmed cell death, such as shrinking of
cell volume and chromatin condensation (ROBERTSON and THOMSON 1982), were not
observed. Similarly, the large vacuoles observed in mec-4 and deg-l-induced necrotic deaths
were not seen (HALL et al. 1997). Four ultrastructural characteristics are associated with the
refractile Pn.p cells observed in lin-24(n423) animals, lin-33(n1043) animals, and
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lin-33(n1043) lin-24(n432) doubly mutant animals (Figure 2): (1) disruption of mitochondrial
ultrastructure, (2) electron dense puncta in the nuclei, (3) dilation of the nuclear membrane
and its associated membranes, (4) electron-dense membranous whorls in the cytoplasm.
These four characteristics distinguish lin-24 and lin-33-induced cell deaths from both
programmed cell deaths and the necrotic deaths associated with mutations in the genes mec-4
and deg-1.
The lin-24 and lin-33 Alleles that Cause Cytotoxicity Are Not Loss-of-function Alleles
In several different screens performed previously, several alleles of lin-24 and lin-33
had been isolated. To rank them by penetrance, we scored the vulvaless phenotype by
assaying the percent of the animals of each strain that could not lay eggs. The penetrance of
the egg-laying defect of eight of the nine lin-24 and lin-33 alleles ranged from 75% to 100%
(Table 1). Using this same assay, we also found that both lin-24 and lin-33 alleles can cause
a semidominant vulvaless phenotype (Table 1). This result gave the first indication that these
alleles were not loss-of-function mutations. We therefore sought to isolate mutations that
reduce or eliminate lin-24 and lin-33 function to define the loss-of-function phenotype of
these genes. Analysis with deficiencies suggested that lin-24(n432)/lin-24(null) and
lin-33(n1043)/lin-33(null) were wild-type (data not shown). Thus, we predicted that we
should be able to isolate lin-24 and lin-33 loss-of-function mutations as dominant suppressors
of the vulvaless phenotype of lin-24(n432) or lin-33(n1043) in an F1 reversion screen. We
mutagenized strains that were homozygous for either lin-24(n432) or lin-33(n1043) and
isolated non-Vul animals from the F1 self-progeny. One isolate from each of these two
screens was a good candidate to be an intragenic revertant allele based on its map position
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(lin-24(n432 n1503) and lin-33(n1043 n1502)) (data not shown). Like the deficiencies, each
of these mutations was able to dominantly suppress the vulvaless phenotype of lin-24(n432)
or lin-33(n1043), suggesting that they were loss-of-function alleles (data not shown).
Animals homozygous for either of the intragenic revertant alleles appeared wild-type,
suggesting that the null phenotype of these genes is not vulvaless and that the previously
isolated alleles of lin-24 and lin-33 that cause the vulvaless phenotype are not
loss-of-function alleles. This was confirmed once we molecularly identified the genes and
isolated deletion alleles of the genes (see below). The deletion alleles did not cause a
vulvaless phenotype, confirming that the alleles of lin-24 and lin-33 that cause cytotoxicity
are not loss of function alleles.
Molecular Identification of lin-24 and lin-33
lin-24 had been previously mapped between unc-22 and dpy-26 on linkage group IV
(FERGUSON and HORVITZ 1985). We further mapped lin-24 to the left of a polymorphism on
cosmid C41D9 between C. elegans strains N2 and N62 (G. GARRIGA, personal
communication) (Figure 3A). We cloned lin-24 using transformation rescue by injecting
wild-type cosmid DNA into lin-24 mutant animals that displayed a recessive vulvaless
phenotype. Although some alleles of lin-24 are semidominant, we choose to use recessive
alleles for these experiments to facilitate transformation rescue. Of the four cosmids we
tested from within the defined interval between unc-22 and the polymorphism, two
overlapping cosmids (T20H7 and B0001) rescued the recessive vulvaless phenotype of
lin-24(n1821) animals in germ-line transformation experiments. A 6.3 kb fragment within
the overlapping region between T20H7 and B0001 containing a single predicted gene,
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B0001. 1, was sufficient to rescue the recessive vulvaless phenotype of lin-24(n2050)
animals. We determined the sequence of the presumptive lin-24 gene in each of the four
different mutants and found that each contained a different missense mutation (Figure 3C).
Six lin-24 cDNAs were isolated from a mixed-stage cDNA library; the longest appeared to
be full-length, as it contains an SL 1 trans-spliced leader sequence. This cDNA established
the gene structure of lin-24 shown in Figure 3B. This gene is highly similar to an
uncharacterized C. elegans gene, C31H1.6.
lin-33 was previously mapped between dpy-13 and unc-8 on linkage group IV
(FERGUSON and HORVITZ 1985). We further mapped lin-33 to the right of a polymorphism
(at position 5412) on cosmid C10G6 between C. elegans strains N2 and CB4856 and to the
left of unc-44 (Figure 3D). We cloned lin-33 by injecting DNA isolated from lin-33 mutant
animals (displaying the dominant vulvaless phenotype) into wild-type animals and
determining the minimal fragment of DNA that caused animals to be vulvaless. Seven PCR
products that had been generated from lin-33(n1302) genomic DNA ( which together covered
most of the relevant 156 kb interval were tested for the ability to phenocopy the vulvaless
phenotype of lin-33(n1302) animals. A single 9 kb PCR product predicted to contain a single
gene, H32C10.2, caused a vulvaless phenotype in wild-type animals. We determined the
sequence of the H32C10.2 locus from each of the five semidominant lin-33 mutants and
found that all five contain the identical missense mutation, changing glutamic acid 230 to
lysine (Figure 3F). Two lin-33 cDNAs have been isolated by Yuji Kohara and coworkers
(KOHARA 1996); one, ykl 122h12, appears to be full-length, as it contains a SL1 trans-spliced
leader sequence. The gene structure of lin-33 based on this cDNA is shown in Figure 3E.
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LIN-24 Contains a Toxin Domain and LIN-33 is a Novel Protein
BLAST and related searches with the LIN-33 protein did not identify any significant
domains or homologs in other organisms. Similar searches using the LIN-24 protein
revealed that it contains a domain found in many bacterial toxins. This domain, spanning
amino acids 62 to 176, is most similar to the Bacillus sphaericus mosquitocidal toxin Mtx3
and related toxins (Figure 4) (Liu et al. 1996). These toxins are thought to function by
binding to eukaryotic cells and aggregating to form holes in the membrane, ultimately
causing osmotic lysis by disrupting membrane permeability (GILBERT 2002). It is tempting
to speculate that LIN-24 may be able to cause cytotoxicity by a mechanism similar to that of
these bacterial toxins. Five of the seven isolated mutations in lin-24 are located in the toxin-
related domain (Figure 4), including three loss-of-function alleles that were isolated in
reversion screens, suggesting that this domain has an important function in LIN-24.
The lin-24(n432) Mutation May Result in a Novel Gene Activity
We identified deletion alleles of lin-24 and lin-33 (lin-24(n4294A) and
lin-33(n4514A)) by screening a library of mutagenized worms. Animals homozygous for
either deletion allele appeared wild-type, demonstrating that the null phenotype of these
genes is not vulvaless (Table 2). The lin-24(n432)/+ and lin-33(n1043)/+ strains have a more
penetrant vulvaless phenotype than lin-24(n432)/lin-24(A) and lin-33(n1043)/lin-33(A),
suggesting that the presence of a wild-type copy of the respective gene can increase the
toxicity of these alleles (Table 2). The relative penetrances of the vulvaless phenotype of the
following lin-24(n432)-containing strains was lin-24(n432)/Df(0%) < lin-24(n432)/+/+
(34%) < lin-24(n432)/+ (55%) < lin-24(n432)/lin-24(n432) (95%). These results indicate
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that an increase in the dosage of the lin-24(+) gene product can result in a decrease in the
percentage of hermaphrodites that are vulvaless. These data suggest that the wild-type lin-24
gene product may antagonize the vulvaless phenotype of the semidominant mutation.
Therefore, the lin-24(n432) mutation probably does not result in an increase in the wild-type
function of the gene product, but rather in the generation of an abnormal cytotoxic gene
product. The complete suppression of the vulvaless phenotype of lin-24(n432) and
lin-33(n1043) when in trans to their respective deletion alleles suggests that they need a
minimum level of expression of either mutant or wild-type gene product to cause the
vulvaless phenotype.
We also isolated a deletion allele of the gene that encodes a protein highly similar to
LIN-24, C31HI. 6. C31H1. 6(n4763A) mutants also appear wild-type, both alone and in
combination with lin-24(n4294A). The wild-type phenotype of the doubly mutant strain,
lin-24(n4294A) C31H1.6(n4763A), suggests that these two genes do not function redundantly
in a pathway that regulates an obvious process.
The lin-24 and lin-33-induced Toxicities Each Require the Function of the Other Gene
In addition to isolating loss-of-function alleles of both lin-24 and lin-33 in their
respective dominant suppressor screens, isolates of the other gene were also isolated in each
screen. One loss-of-function allele of lin-33, n1968, was isolated in the lin-24(n432) screen
and one loss-of-function allele of lin-24, n2333, was isolated in the lin-33(n1043) screen.
These results suggested a genetic interaction between lin-24 and lin-33 that was further
explored using the deletion alleles, which are molecular nulls. Strains of the genotypes
lin-33(n1043) lin-24(n4294A)/ lin-33(n1043) lin-24(n4294A) or lin-33(n4514A)
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lin-24(nl043)/lin-33(n4514A) lin-24(n1043) are wild-type (Table 2). Additionally, as
suggested by their isolation in a Fi screen, the loss-of-function alleles of lin-24 and lin-33 can
suppress the vulvaless phenotype caused by mutations in the other gene when they are
present only in one copy (data not shown). For example, an animal of the genotype
lin-33(nl 043) lin-24(n4294A)l lin-33(n1043) lin-24(+) is not vulvaless, so a loss of one copy
of lin-24 is able to suppress the vulvaless phenotype of a lin-33 mutant animal. These results
show that the lin-24 and lin-33 requires the function of the other to induce cell death.
Genes that Function in the Engulfment Process of Programmed Cell Death Are
Required for the lin-24 and lin-33-Induced Cytotoxicity
To determine if genes known to be required for the programmed cell deaths in C.
elegans are also required for the lin-24 or lin-33-induced cytotoxicity, we tested whether
mutations in such genes affect the vulvaless phenotype of lin-24(n432)/+ and lin-33(1043)/+
animals (Figure 5). We found that the penetrances of the Vul phenotype of lin-24(n432)/+
and lin-33(n1043)/+ animals were not affected by loss-of-function alleles of ced-3 or ced-4
or by a gain-of-function allele of ced-9. A loss-of-function allele of egl-1 partially
suppressed the Vul phenotype, although not to the same level as the modifiers discussed
below. This result demonstrates that lin-24 and lin-33-induced cell death does not require
most of the killing genes in the pathway of programmed cell death.
The genes of the ced-2, -5, -10, and -12 engulfment pathway were required for the
lin-24- and lin-33-induced deaths (Figure 5). These four genes function together in one of
two engulfment pathways involved in corpse removal. ced-12 mutations almost completely
eliminated the cytotoxicity of either lin-24 or lin-33. The ced-1, ced-6, and ced-7 genes from
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the second engulfment pathway are not required for these deaths. For example, the
cytotoxicity is unchanged in ced-7 mutant animals. The engulfment genes have been shown
to influence the killing of cells that undergo programmed cell death (REDDIEN et al. 2001).
Our findings indicate that some engulfment genes are also required for mediating the killing
and cytotoxicity caused by mutations in lin-24 and lin-33. Therefore, we believe that this
cytotoxicity is due, in part, to injury mediated by the gene products of ced-2, -5, -10, and -12.
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DISCUSSION
In this work we have identified two genes that, when mutated, can cause the
inappropriate deaths of Pn.p cells, a subset of which give rise to the vulva. These genes
appear to work together to mediate this cytotoxicity. The deaths caused by lin-24 and lin-33
mutations are cytologically distinct from the previously characterized deaths that have been
observed in C elegans, namely programmed cell death and necrotic death. lin-24 and lin-33
cytotoxicity does not require most of the execution genes of programmed cell death, as the
cytotoxicity persists in animals harboring mutations in the genes the Bcl-2 family member
ced-9, the Apaf-1 homolog ced-4, and the caspase encoding gene ced-3. egl-1 may be
partially required for the cytotoxicity, since egl-(lf) (loss of function) can partially suppress
the vulvaless phenotype of both lin-24(n432) and lin-33(n1043) animals. The partial
suppression by egl-1 is particularly interesting, as it suggests that the most upstream gene
that functions in all somatic programmed cell deaths may also function independently from
ced-3, ced-4, and ced-9 in non-programmed cell deaths. The cytotoxicity requires the
functions of the genes from one of the two partially redundant programmed cell death corpse
engulfment pathways, mediated by ced-2, -5, -10, and -12.
ced-2, -5, -10, and -12 function in parallel to the genes ced-1, -6, and -7 for the rapid
removal of corpses generated by programmed cell death. Whereas the function of the ced-1,
-6, -7 pathway is unclear, the ced-2, -5, -10, -12 pathway is likely a signal transduction
pathway, the output of which causes cytoskeletal rearrangement (MANGAHAS and ZHOU
2005; REDDIEN and HORVITZ 2004). CED-2 appears to be an SH2 (Src-homology 2) and
SH3 (Src-homology 3) domain containing adapter protein (REDDIEN and HORVITz 2000),
CED-10 is a Racl-like GTPase (REDDIEN and HORVITZ 2000), and CED-5 and CED-12
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exchange Rac 1 GDP for GTP (GUMIENNY et al. 2001; Wu and HORVITZ 1998; WU et al.
2001; ZHOU et al. 2001). The mammalian counterparts of CED-2, CED-5, and CED-12
regulate Rac (AKAKURA et al. 2005; Lu and RAVICHANDRAN 2006), a member of the Ras
GTPase superfamily family that includes Rho, Rac, and Cdc42, each of which has a
well-established role in cytoskeletal reorganization (WENNERBERG and DER 2004).
Cytoskeletal reorganization is important for the process of polarized surface extension that is
critical for cell migration, axonal outgrowth, and phagocytosis.
Whereas the ced-1, -6, -7 pathway appears to be specific for programmed cell death,
the ced-2, -5, -10, -12 pathway has been shown to be involved in several processes in C.
elegans such as: programmed cell death, distal tip cell migration, axonal outgrowth, and now
lin-24/lin-33-mediated cytotoxicity (MANGAHAS and ZHOU 2005; REDDIEN and HORVITZ
2004). Our work suggests that the ced-2, -5, -10, -12 pathway might respond to a signal
presented on the cell surface of a cell that is sick or dying (Figure 6). It is possible that the
signal presented by the cells affected by lin-24/lin-33-induced toxicity is the same as that
recognized by the ced-2, -5, -10, -12 pathway in programmed cell death. The ced-1, -6, -7
pathway, in contrast, may recognize a different signal that is specific to corpses generated by
programmed cell death. Although less likely, it is possible that ced-2, -5, -10, and -12
function within the dying cells rather than engulfing cells (although this is certainly not the
case in programmed cell death, where the engulfment genes are necessary in the neighboring
cells that do the engulfing, but not in the dying cells). This possibility needs to be explored
by determining the site of action of these genes in this lin-24- and lin-33-mediated
cytotoxicity.
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The observation that mutations in ced-2, -5, -10, and -12 reduce lin-24- and
lin-33-induced cytotoxicity parallels the observation that engulfment genes are involved not
only in engulfing corpses generated by programmed cell death, but also in the execution of
programmed cell death (REDDIEN et al. 2001). This conclusion was based on the observation
that mutations in engulfment genes enhance the cell-death defect observed in a sensitized
background containing a weak ced-3 loss-of-function allele. There are also a few
programmed cell deaths, such as death of one of the pair of cells B.alapaav and B.arapaav in
the male tail, that appear to be entirely dependent on engulfment (HEDGECOCK et al. 1983).
Additional studies of the lin-24- and lin-33-mediated cytotoxicity could provide valuable
insight into how engulfment contributes to both this cytotoxicity and possibly programmed
cell death. If the ced-2, -5, -10, -12 pathway recognizes a signal presented by the sick Pn.p
cells in lin-24 and lin-33 mutants, it may be possible to isolate mutations in this signal by
screening for suppressors of the vulvaless phenotype caused by mutations in lin-24 and
lin-33.
In contrast to both programmed cell death and lin-24- and lin-33-mediated
cytotoxicity, necrotic deaths do not involve the function of engulfment genes. Specifically,
engulfment genes function in the engulfment of the necrotic corpses generated by mutations
in mec-4 and deg-3, but they affect only the timing of the disappearance of these corpses and
not cell survival (CHUNG et al. 2000).
One other C. elegans cell death seems to require the function of the engulfment
genes, which is the death of the Pn.p cells in animals containing a mutation in pvl-5, a gene
not yet identified molecularly (JOSHI and EISENMANN 2004). When observed by Nomarski
optics, the abnormal Pn.p cell nuclei in animals with the pvl-5 mutation resemble those
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observed in mutant lin-24 and lin-33 animals. These pvl-5-induced deaths are genetically
distinct from lin-24- and lin-33-induced deaths, however, as the pvl-5-induced deaths require
the caspase encoding gene ced-3. pvl-5-induced deaths do not require the activity of ced-4,
which encodes the Apaf- 1 homolog that activates CED-3, making these deaths also distinct
from programmed cell deaths (JOSHI and EISENMANN 2004). pvl-5-induced deaths do occur
in animals lacking any one engulfment gene (in contrast to the lin-24 or lin-33-induced
deaths, which require ced-2, -5, -10, and -12), but these deaths do not occur in ced-1; ced-5
double mutants (JOSHI and EISENMANN 2004). Thus, at least one engulfment pathway must
be functional in pvl-5 mutant worms to allow killing. The authors suggest that pvl-5 might
function to protect the cells from inappropriate activation of ced-3-dependent programmed
cell death by a pathway independent of its physiological activator ced-4 (JOSHI and
EISENMANN 2004). The mechanism of this protection is not known.
We are very interested in understanding how mutations in lin-24 and lin-33 induce
cell death, and the toxin-like domain in LIN-24 suggests a possible mechanism. Related
toxins are thought to form membrane complexes that alter eukaryotic membrane permeability
and cause osmotic lysis (GILBERT 2002). Perhaps the lin-24 and lin-33 mutations
inappropriately activate the toxin activity of the toxin-like domain of LIN-24, causing the
deaths of the specific cells in which they are both expressed. The neomorphic activity of the
allele lin-24(n432), which causes the vulvaless phenotype, is consistent with our data.
Given the similarity of LIN-24 to bacterial toxins, what might be the wild-type
function of the lin-24 gene product in C. elegans? Neither loss of lin-24 function alone, nor
loss of lin-24 function in combination with loss-of-function of its close homologue C31H1.6,
results in any obvious abnormal phenotype. Members of the Caenorhabditis genus are one
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of a small number of eukaryotic organisms that contain members of this family in their
genomes. Almost all LIN-24 homologs are found in bacteria, which are the food source of
C. elegans. In such bacteria, these toxins are produced and are capable of killing animals
such as mosquitoes and cattle by forming oligomers that increase membrane permeability
and cause osmotic lysis. Perhaps the wild-type LIN-24 normally functions to interact with
bacterial toxins and inactivate them, possibly by a mechanism that requires LIN-33. Such an
activity might allow C. elegans to be able to eat the bacteria that produce such toxins that are
normally capable of killing.
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FUTURE DIRECTIONS
The next step in this project is to determine the mechanism by which lin-24 and
lin-33 mutations cause cytotoxicity. A genetic approach to this would be to perform a
large-scale F2 and F3 suppression screen of the vulvaless phenotype caused by mutations in
lin-24 and lin-33. In addition to alleles of lin-24 and lin-33, alleles of some engulfment
genes should be isolated. Previously uncharacterized genes might also be identified, some of
which may function in programmed cell death and some of which might function solely in
the cytotoxicity of lin-24 and lin-33. It would be very exciting to try to use this sort of screen
to isolate the gene(s) encoding the signal presented by dying cells that are recognized by
neighboring cells to trigger engulfment.
I would like to determine the expression patterns of lin-24 and lin-33. Our hypothesis
is that the expression patterns might inform us about why the Pn.p cells appear to be the only
cells affected by these mutations. Perhaps they are the only cells that express both lin-24 and
lin-33. I have already made antibodies to LIN-24 and LIN-33 and transcriptional gfp reporter
constructs for both genes, but analyses with these reagents have not been useful in
determining the expression pattern of these genes. Also, I am interested in determining
whether ced-2, -5, -10, and -12 work non-cell autonomously in lin-24/lin-33-mediated
cytotoxicity, as they do in programmed cell death. I would also like to determine whether
lin-24 and lin-33 work cell autonomously or non-cell autonomously.
Establishing if there is a direct physical interaction between LIN-24 and LIN-33
would confirm part of our model for the activity of these two proteins. The possible
interaction could be explored by either yeast two-hybrid analysis or co-immunoprecipitation
experiments using our anti-LIN-24 antibody, which works on western blots.
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I wish to test the hypothesis put forth in this chapter that the wild-type function of
lin-24 might be to defend worms against one of the toxins that their food source (bacteria) use
to kill organisms. To test this initially, I would examine if loss of lin-24 function and the
function of the highly similar C31H1.6 gene alters the ability of C. elegans to survive on
Pseudomonas aeruginosa. We would examine Pseudomonas aeruginosa first, because
survival assays have been established for this organism (TAN et al. 1999) and it possesses a
cytotoxin that is somewhat similar to LIN-24 (HAYASHI et al. 1989).
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EXPERIMENTAL PROCEDURES
Strains and General Techniques
Strains were cultured as described by BRENNER (1974) and grown at 200 C. The
Bristol strain N2 was used as the wild-type strain, except in multifactor mapping experiments
that used the polymorphic wild-type strains N62 and CB4856 (WICKS et al. 2001). The
mutations used in the study are listed below, and a description, unless otherwise noted, can
be found in RIDDLE (1997):
LGI: ced-](el 735), ced-12(n3261) (ZHOU et al. 2001)
LGIII: ced-9(n1950), ced-4(n1162), ced-6(n1813), ced-7(n1996)
LGIV: lin-24(n432, n1057), lin-24(n1821, n2050) (S. G. CLARK & H. R. HORVITZ,
unpublished results), lin-24(n2258, n2333, n4294) (this study), lin-24(n432 n1503) (this
study), lin-33(n1043, n1044) lin-33(nl110) (M. K. EDWARDS & H. R. HORVITZ,
unpublished results), lin-33(n1302) (J. H. THOMAS & H. R. HORVITZ, unpublished
results), lin-24(n1968, n2003, n4514) (this study), lin-33(n1043 n1502) (this study),
ced-3(n717), ced-2(el752), ced-5(nl812), ced-10(n1993), unc-44(e362)
LGV: unc-76(e911), egl-](nl084 n3082) (CONRADT and HORVITZ 1998)
Assay for Vulvaless Animals
Only worms propagated through two generations without starvation were scored.
Five-centimeter plates were seeded 12 to 24 hours prior to assay with an overnight culture of
the E. coli strain OP50. Single L4 animals were placed one per plate. Sixteen to 18 hours
later, plates were examined for the presence of gravid adults. Plates with gravid adults were
scored for the presence or absence of eggs. Plates without any eggs were scored as vulvaless.
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To assay for suppression of lin-24(n432) and lin-33(n1043)-induced death by
loss-of-function alleles of genes that function in programmed cell death, we modified the
above assay. Homozygous males (e.g., ced-5(n1812) lin-24(n432)) were generated by heat
shock and mated with homozygous unc-76(e911) marked strains (e.g., ced-5(1812);
unc- 76(e911)), and three to five days later non-Unc L4 hermaphrodites were assayed as
described above.
The assay for the dosage studies of lin-24 not included in Table 2 was performed as
previously described (FERGUSON and HORVITZ 1985).
Nomarski Observation of Pn.p Cells
Pn.p cells in lin-24 or lin-33 mutant animals were observed using Nomarski
differential interference contrast microscopy at different times during development as
previously described (SULSTON and HORVITZ 1977).
Electron Microscopy
Nomarski differential interference contrast microscopy was used to select a nematode
with refractile bodies, and digital images were taken to note their positions. Mutant animals
were recovered from the slide and fixed as previously described (BARGMANN et al. 1993).
The fixed, embedded animals were sectioned as previously described (GUMIENNY et al.
1999) and photographed using a JEOL 12000CX electron microscope at 80 kv. After finding
the location of the anus or the gonad in the EM photographs, nuclei were counted by
examining EM photographs of adjacent sections and the cell that corresponded to the
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refractile Pn.p cell identified in the original digital Nomarski image was identified and
examined.
Dominant Suppression Screen for Revertant Alleles of lin-24(n432) and lin-33(nl043)
We mutagenized homozygous L4 or early adult hermaphrodites homozygous for
either lin-24(n432) or lin-33(n1043) with ethyl methanesulfonate (EMS) as previously
described (BRENNER 1974). After mutagenesis, three to four Po hermaphrodites were placed
on each five-centimeter plate. F 1 self-progeny animals that were non-Vul were picked to
individual plates. If greater than 10% of F2 animals were non-Vul, individual non-Vul F2
animals were picked to separate plates and assayed the next generation for suppression of the
Vul phenotype.
Cloning of lin-24 and lin-33
Using standard three-point and polymorphism mapping, we placed lin-24(n1057) and
lin-33(n1043) in small map intervals. To clone the gene lin-24 we performed transformation
rescue experiments as previously described (MELLO et al. 1991) using pRF4 plasmid as a
coinjection marker. To clone the gene lin-33 we injected DNA from lin-33 mutant animals
into unc-76(e91 1) animals, using wild-type unc-76 DNA as a co-injection marker, to identify
DNA that caused the vulvaless phenotype. The DNA injected for the lin-33 cloning were
PCR products generated from lin-33(n1302) animals using the Expand Long Template PCR
System (Roche Applied Science, Indianapolis, IN) according to manufacturer's instructions.
Isolation of lin-24 cDNAs
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A 10.8 kb SmaI-Ncol fragment from cosmid T20H7 was used to screen more than
800,000 plaques of a X ZAP cDNA library derived from mixed-stage poly(A)-positive RNA
collection as previously described (BARSTEAD and WATERSTON 1989). Fourteen plaques
were isolated, six of which hybridized to fragments of the 10.8 kb fragment required for
rescue.
Determination of Mutant Allele Sequences
We used PCR-amplified regions of genomic DNA to determine mutant sequences.
For all alleles of lin-24 and lin-33, we determined the sequence of all exons and splice
junctions. Sequences were determined using an ABI Prism 3100 Genetic Analyzer.
Isolation of Deletion Alleles
Genomic DNA pools from EMS-mutagenized animals were screened for deletions
using PCR as previously described (CEOL and HORVITZ 2001). Deletion mutants were
isolated from frozen stocks and backcrossed to the wild type six times. lin-24(n4294)
removes nucleotides 2259 to 3253 of cosmid B0001. lin-33(n4514) removes nucleotides
28902 to 29937 of cosmid H32C10. C31H1.6(n4763) removes nucleotides 27211 to 28463
of cosmid C31H1.
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FIGURE LEGENDS
Figure 1. The Pn.p Cells in lin-24(n432) and lin-33(nl043) Mutants Look Abnormal
and Appear Different from Both Necrotic and Programmed Cell Death Corpses
(A) Normarski photomicrograph of representative abnormal Pn.p cells in a lin-33(n1043)
L1 larva. The white arrows point to two Pn.p cells that have the refractile appearance often
observed in lin-24(n432) and lin-33(n1043) animals.
(B) Nomarski photomicrograph of corpses generated by programmed cell death in a
ced-5(lf mutant.
(C) Nomarski photomicrograph of a necrotic corpse in a mec-4(d) mutant (photograph
provided by Monica Driscoll).
Figure 2. Ultrastructural Characteristics of the Refractile Pn.p cells in lin-24(n432) and
lin-33(n1043) Mutants
(A) Electron photomicrograph of the refractile body corresponding to P10.p in a
lin-33(n1043) mutant. Four abnormal ultrastructural characteristics of these animals are
indicated: (1) dilated mitochondrion with disrupted internal architecture, (2) electron dense
puncta in the nucleus, (3) dilation of nuclear and associated membranes, and (4) dense
membranous whorls. (5) One of several mitochondria in neighboring cells with normal
architecture. Note that these four abnormal characteristics are not observed in the adjacent
cells, which all have normal cellular architecture.
(B) Increased magnification of (A) showing the disrupted mitochondrion.
(C) Increased magnification of (A) showing a mitochondrion with normal architecture.
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(D) Increased magnification of (A) showing the electron-dense nuclear punctations and
membranous whorls.
Figure 3. Molecular Identification of lin-24 and lin-33
(A) Genetic and physical maps of the lin-24 region. The four cosmids shown were tested
for their abilities to rescue the recessive Vul phenotype of lin-24 mutants. The overlapping
cosmids B0001 and T20H7 rescued the Vul phenotype. An NcoI-HindIII fragment
containing the gene BOO01. 1 also to rescued.
(B) The structure of the lin-24 gene as deduced from genomic and cDNA sequences. The
location of the deletion lin-24(n4294) is indicated by the horizontal line.
(C) The sequences of the lin-24 mutations. The mutated bases are underlined.
(D) Genetic and physical maps of the lin-33 region. PCR products generated from
Iin-33(n1302) genomic DNA spanning most of the shown interval were tested for the ability
to phenocopy the dominant vulvaless phenotype of the mutant animals when injected into
lin-33(+) animals. The 26 kb PCR product #6 was able to cause the vulvaless phenotype.
The 9 kb PCR product containing only the gene H32C10.2 was also able to cause the Vul
phenotype.
(E) The structure of the lin-33 gene as deduced from genomic and cDNA sequences. The
location of the deletion lin-33(n4514) is indicated by the horizontal line.
(F) The sequences of the lin-33 mutations. The mutated bases are underlined.
Figure 4. LIN-24 Contains a Domain Similar to that Found in Bacterial Toxins
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Sequence alignment of LIN-24 and the 3.58-kilodalton-mosquitocidal toxin Mtx3 found in
Bacillus sphaericus. Numbers at the right and left indicate amino acid positions. Identical
residues are colored blue, and similar residues are colored red. Missense mutations found
within the region of homology are indicated.
Figure 5. The Cytotoxicity of lin-24 and lin-33 Is Suppressed by Mutations in the
Engulfment Genes ced-2, ced-5, ced-lO0, and ced-12
We analyzed lin-33(n1043)/+; ced/ced and lin-24(n432)/+; ced/ced mutants as described in
Experimental Procedures. An average of 76 ± 29 (± standard deviation) animals were
assayed for each genotype.
(A) The penetrance of the Vul phenotype of lin-33(n1043)/+ animals was modified by
mutations in some of the genes required for programmed cell death. Genes on the X-axis are
organized in the following order: cell killing genes in order of action (egl-1, ced-9, ced-4,
ced-3); one partially redundant engulfment pathway (ced-1, ced-6, ced-7); the other partially
redundant engulfment pathway (ced-2, ced-5, ced-10, ced-12).
(B) The penetrance of the Vul phenotype of lin-24(n432)/+ animals was modified by
mutations in some of the genes required for programmed cell death.
Figure 6. Model for the Effects of Engulfment on lin-24/lin-33-induced Cytotoxicity
Mutations in lin-24 and lin-33 make the Pn.p cells sick, possibly by a mechanism
related to the toxin domain of lin-24. A signal of this sickness is presented on the cell
membrane and recognized by a neighboring cell. The neighboring cell then either removes
or injures the sick cell in an process that requires the engulfment genes ced-2, ced-5, ced-10,
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and ced-12, which likely act by reorganizing the actin cytoskeleton (adapted from REDDIEN
and HORVITZ (2004)).
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Table 1. lin-24 and lin-33 Allele
Genotype % Vul (n)
Wild type 0 (89)
lin-24(n432) 92 (90)
lin-24(n432)/+ 66 (109)
lin-24(nl821) 75 (89)
lin-24(n1821)/+ 0 (72)
lin-24(n2050) 91 (87)
lin-24(n2050)/+ 0 (71)
lin-24(n1057) 2 (90)
lin-24(n105.7)/+ 41(74)
lin-33(nl043) 97 (90)
lin-33(n1043)/+ 77 (121)
lin-33(nl 044) 96 (90)
lin-33(nl110) 92 (88)
lin-33(n1302) 100 (90)
lin-33(n2003) 99 (90)
lin-33(n 1043) lin-24(n432) 97 (89)
The penetrance of the Vul phenotype (%) was
determined as described in Experimental
Procedures. Heterozygous animals were
generated by crossing homozygous mutant
males with unc-76(e911) hermaphrodites, and
non-Unc progeny were scored. n, number of
animals.
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Strengths
Table 2. Gene Dosage and Gene Interaction
Studies of Ilin-24 and lin-33 Alleles
Genotype % Vul (n)
Wild typec 0 (89)
lin-24(n432)/lin-24(n432)c 92 (90)
lin-24(n4294A)/lin-24(n4294A) 0 (102)
lin-24(n432)/lin-24(n4294A)" 3 (89)
lin-24(n432)/+c 66 (109)
+/+/+d 0 (33)
lin-33(nl 043)/lin-33(n1043)c 97 (90)
lin-33(n4514A)/lin-33(n4514A) 0 (72)
lin-33(n1043)/1in-33(n4514A)b 21(77)
lin-33(n1043)/+c 77 (121)
+/+/+e 0(53)
lin-33(n1043) lin-24(n432)c 97 (89)
lin-33(n1043) lin-24(n4294A) 0 (56)
lin-33(n4514A) lin-24(n432) 0 (60)
The number of Vul animals was counted as
described in Experimental Procedures. n, number
of animals.
" lin-24(n432) homzygous males were mated with
lin-24(n4294A) hermaphrodites, which were cis-
marked with dpy-4(e1166), and non-Dpy cross
progeny were scored.
b lin-33(n1043) homozygous males were mated
with lin-33(n4514A) hermaphrodites, which were
cis-marked with unc-30(el91), and non-Unc cross
progeny were scored.
c These data are from Table 1.
d This strain was of genotype dpy-13(e184)
unc-24(e138); mDp4; only non-Dpy non-Unc
animals were scored.
e This strain was of genotype unc-30(e191)
dpy-4(e1166); yDpl; only non-Unc non-Dpy
animals were scored.
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